UCL CfMR5

View our CfMR interactive map

If you are at UCL and interested in working with the CfMR, please email Michael Duchen


Prof Michael Hanna

Photo

Personal Profile

Name: Michael Hanna Email: m.hanna@ucl.ac.uk
Title: Prof Tel: 020 3448 3014
Department: Molecular Neuroscience Fax:
Position: Professor in Clinical Neurology Address: National Hospital for Neurology & Neurosurgery, UCL, Queen Square, London , WC1N 3BG
Research Domain: Neuroscience Web Page: Personal Web Page

Profile

Research Description

My group has a long standing clinical and genetic research interest in neurological channelopathies and in mitochondrial neuromuscular diseases. We are also interested in mechanisms of muscle degeneration in acquired muscle disease particularly IBM.

My research has focused on improved understanding of the molecular genetics basis and molecular mechanisms of neurological diseases caused by mitochondrial dysfunction and by ion channel dysfunction. Many of these diseases particularly affect the neuromuscular system and my clinical specialist interest has focused on developing better services for patients with neuromuscular neurological diseases.

Ion Channel Research Programme

Many important neurological diseases are episodic causing patients to experience attacks of unpredictable severe neurological dysfunction separated by periods of apparent normality. The commonest episodic neurological disorders are epilepsy and migraine but their precise molecular pathophysiology is an important unsolved neuroscience      challenge. In addition, there are many severe disabling disorders of episodic muscle dysfunction such as episodic total muscle periodic paralysis and intermittent and severe disabling muscle myotonic stiffness. 

Mitochondrial Research Programme

I have a particular interest in the link between mitochondrial DNA mutations and human disease. We have defined a large number of human pathological mtDNA mutations and have elucidated their molecular pathogenesis through various expression systems including human primary muscle cell cultures. We have established that approximately 70% of human adult mitochondrial disease is caused by primary mtDNA mutations. More recently we have used whole exome genetic approaches in the remaining 30% of adult case and have recently been successful in identifying new nuclear genes that encode proteins that are targeted to the mitochondria and control respiratory chain assembly and mitochondrial fission.


Research Activities

Commissioning neuromuscular services in the UK

Human neuromuscular diseases

NIHR Translational Research Collaboration National Lead for Neuromuscular Theme

Education Description

UCL Collaborators

Dr Rosaline Quinlivan; Dr Fatima Jaffer; Prof Francesco Muntoni

External Collaborators

Publications

    2014

    • Cortese A, Brady S, Greensmith L, Holton J, Hanna MG, Fisher EMC, Fratta P, Simone R, De Silva R, Lashley T, Plagnol V, Acevedo-Arozena A (2014). Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy. Neurobiology of Aging, 35(6), 1491 - 1498. doi:10.1016/j.neurobiolaging.2013.12.029
    • Fratta P, Collins T, Devoy A, Fisher EMC, Nethisinghe S, Giunti P, Hanna MG, Pemble S, Sweeney MG (2014). Sequencing analysis of the spinal bulbar muscular atrophy CAG expansion reveals absence of repeat interruptions. Neurobiology of Aging, 35(2), - . doi:10.1016/j.neurobiolaging.2013.07.015
    • Morrow JM, Sinclair CDJ, Reilly MM, Hanna MG, Yousry TA, Thornton JS, Fischmann A (2014). Reproducibility, and age, body-weight and gender dependency of candidate skeletal muscle MRI outcome measures in healthy volunteers. European Radiology, 24(7), 1610 - 1620. doi:10.1007/s00330-014-3145-6
    • Gang Q, Bettencourt C, Machado P, Hanna MG, Houlden H (2014). Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.. Orphanet J Rare Dis, 9, 88 - . doi:10.1186/1750-1172-9-88
    • Fratta P, Nirmalananthan N, Masset L, Skorupinska I, Collins T, Cortese A, Pemble S, Malaspina A, Fisher EM, Greensmith L, Hanna MG (2014). Correlation of clinical and molecular features in spinal bulbar muscular atrophy.. Neurology, , - . doi:10.1212/WNL.0000000000000507
    • Graham CD, Weinman J, Sadjadi R, Chalder T, Petty R, Hanna MG, Turner C, Parton M, Maddison P, Radunovic A, Longman C, Robb Y, Bushby K, Hilton-Jones D, Rose MR (2014). A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease. CLINICAL REHABILITATION, 28(5), 508 - 519. doi:10.1177/0269215513511340
    • Foley AR, Pitceathly RD, He J, Kim J, Pearson NM, Muntoni F, Hanna MG (2014). Whole-genome sequencing and the clinician: a tale of two cities.. J Neurol Neurosurg Psychiatry, , - . doi:10.1136/jnnp-2013-306264
    • Ke Q, Qi M, Wu W, Luo B, Hanna M, Herr B, Griggs RC, Neurological CI (2014). Lengthening our perspective: Morphological, cellular, and molecular responses to eccentric exercise. MUSCLE & NERVE, 49(2), 171 - 174.
    • Cortese A, Brady S, Greensmith L, Holton J, Hanna MG, Fisher EMC, Fratta P, Simone R, De Silva R, Lashley T, Plagnol V, Acevedo-Arozena A (2014). Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy. Neurobiology of Aging, 35(6), 1491 - 1498. doi:10.1016/j.neurobiolaging.2013.12.029
    • Tan SV, Z'Graggen WJ, Boerio D, Rayan DR, Norwood F, Ruddy D, Howard R, Hanna MG, Bostock H (2014). CHLORIDE CHANNELS IN MYOTONIA CONGENITA ASSESSED BY VELOCITY RECOVERY CYCLES. MUSCLE & NERVE, 49(6), 845 - 857. doi:10.1002/mus.24072
    • Montague K, Malik B, Gray AL, La Spada AR, Hanna MG, Szabadkai G, Greensmith L (2014). Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy.. Brain, , - . doi:10.1093/brain/awu114
    • Birbeck GL, Hanna MG, Griggs RC (2014). Global opportunities and challenges for clinical neuroscience.. JAMA, 311(16), 1609 - 1610. doi:10.1001/jama.2014.2744
    • Morrow JM, Sinclair CD, Fischmann A, Reilly MM, Hanna MG, Yousry TA, Thornton JS (2014). Reproducibility, and age, body-weight and gender dependency of candidate skeletal muscle MRI outcome measures in healthy volunteers.. Eur Radiol, , - . doi:10.1007/s00330-014-3145-6
    • Brady S, Squier W, Sewry C, Hanna M, Hilton-Jones D, Holton JL (2014). A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis.. BMJ Open, 4(4), e004552 - . doi:10.1136/bmjopen-2013-004552
    • Fischmann A, Morrow JM, Sinclair CDJ, Reilly MM, Hanna MG, Yousry T, Thornton JS (2014). Improved anatomical reproducibility in quantitative lower-limb muscle MRI. Journal of Magnetic Resonance Imaging, 39(4), 1033 - 1038. doi:10.1002/jmri.24220
    • Hiscock A, Dewar L, Parton M, Machado P, Hanna M, Ramdharry G (2014). Frequency and circumstances of falls in people with inclusion body myositis: A questionnaire survey to explore falls management and physiotherapy provision. Physiotherapy (United Kingdom), 100(1), 61 - 65. doi:10.1016/j.physio.2013.06.002
    • Graves TD, Cha YH, Hahn AF, Barohn R, Salajegheh MK, Griggs RC, Bundy BN, Jen JC, Baloh RW, Hanna MG, on behalf of the CINCH Investigators (2014). Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.. Brain, , - . doi:10.1093/brain/awu012
    • Willis TA, Hollingsworth KG, Coombs A, Sveen ML, Andersen S, Stojkovic T, Eagle M, Mayhew A, de Sousa PL, Dewar L, Morrow JM, Sinclair CD, Thornton JS, Bushby K, Lochmuller H, Hanna MG, Hogrel JY, Carlier PG, Vissing J, Straub V (2014). Quantitative Magnetic Resonance Imaging in Limb-Girdle Muscular Dystrophy 2I: A Multinational Cross-Sectional Study.. PLoS One, 9(2), e90377 - . doi:10.1371/journal.pone.0090377
    • Ke Q, Qi M, Luo B, Herr B, Griggs RC, Wu W, Hanna M (2014). Rare disease centers for periodic paralysis: China versus the United States and United Kingdom. Muscle and Nerve, 49(2), 171 - 174. doi:10.1002/mus.23970
    • Brady S, Squier W, Sewry CA, Hanna M, Hilton-Jones D, Holton JL (2014). Evaluation of classical and novel histopathological features in the diagnosis of inclusion body myositis.

    2013

    • Pitceathly RD, Taanman JW, Rahman S, Meunier B, Sadowski M, Cirak S, Hargreaves I, Land JM, Nanji T, Polke JM, Woodward CE, Sweeney MG, Solanki S, Foley AR, Hurles ME, Stalker J, Blake J, Holton JL, Phadke R, Muntoni F, Reilly MM, Hanna MG (2013). COX10 Mutations Resulting in Complex Multisystem Mitochondrial Disease That Remains Stable Into Adulthood. JAMA Neurol., , - . doi:10.1001/jamaneurol.2013.3242
    • Pitceathly RD, Tomlinson SE, Hargreaves I, Bhardwaj N, Holton JL, Morrow JM, Evans J, Smith C, Fratter C, Woodward CE, Sweeney MG, Rahman S, Hanna MG (2013). Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase γ mutations.. J Neurol Neurosurg Psychiatry, 84(1), 107 - 110. doi:10.1136/jnnp-2012-303232
    • Pitceathly RDS, Rahman S, Wedatilake Y, Polke JM, Cirak S, Foley AR, Sailer A, Hurles ME, Stalker J, Hargreaves I, Woodward CE, Sweeney MG, Muntoni F, Houlden H, Taanman J-W, Hanna MG (2013). NDUFA4 mutations underlie dysfunction of a cytochrome C oxidase subunit linked to human neurological disease. Cell Reports, 4(2), 402 - 402. doi:10.1016/j.celrep.2013.06.032
    • Pitceathly RDS, Rahman S, Houlden H, Hanna M, Wedatilake Y, Polke JM, Woodward CE, Sweeney MG, Hargreaves I, Cirak S, Foley A, Muntoni F, Sailer A, Hurles ME, Stalker J, Taanman J-W (2013). NDUFA4 Mutations Underlie Dysfunction of a Cytochrome c Oxidase Subunit Linked to Human Neurological Disease. Cell Reports, 3(6), 1795 - 1805. doi:10.1016/j.celrep.2013.05.005
    • Morrow JM, Sinclair CDJ, Fischmann A, Hanna MG, Thornton JS, Yousry TA, Reilly MM (2013). MEASURING THE UNMEASURABLE: MRI QUANTIFICATION OF DISEASE PROGRESSION IN CMT1A OVER 12 MONTHS.
    • Wallace A, Dewar E, Skorupinska M, Laura M, Morrow JM, Sterr A, Hanna MG, Skorupinska I, Trenell M, Baio G, Reilly MM, Ramdharry GM (2013). EVALUATING THE BENEFITS OF COMMUNITY BASED AEROBIC TRAINING ON THE PHYSICAL HEALTH AND WELL-BEING OF PEOPLE WITH NEUROMUSCULAR DISEASES: A PILOT STUDY.
    • Sarkozy A, Hicks D, Hudson J, Laval SH, Barresi R, Hilton-Jones D, Deschauer M, Harris E, Rufibach L, Hwang E, Bashir R, Walter MC, Krause S, van den Bergh P, Illa I, Pénisson-Besnier I, De Waele L, Turnbull D, Guglieri M, Schrank B, Schoser B, Seeger J, Schreiber H, Gläser D, Eagle M, Bailey G, Walters R, Longman C, Norwood F, Winer J, Muntoni F, Hanna M, Roberts M, Bindoff LA, Brierley C, Cooper RG, Cottrell DA, Davies NP, Gibson A, Gorman GS, Hammans S, Jackson AP, Khan A, Lane R, McConville J, McEntagart M, Al-Memar A, Nixon J, Panicker J, Parton M, Petty R, Price CJ, Rakowicz W, Ray P, Schapira AH, Swingler R, Turner C, Wagner KR, Maddison P, Shaw PJ, Straub V, Bushby K, Lochmüller H (2013). ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation.. Hum Mutat, 34(8), 1111 - 1118. doi:10.1002/humu.22342
    • Pitceathly RD, Rahman S, Wedatilake Y, Polke JM, Cirak S, Foley AR, Sailer A, Hurles ME, Stalker J, Hargreaves I, Woodward CE, Sweeney MG, Muntoni F, Houlden H, UK10K Consortium , Taanman JW, Hanna MG (2013). NDUFA4 Mutations Underlie Dysfunction of a Cytochrome c Oxidase Subunit Linked to Human Neurological Disease.. Cell Rep, , - . doi:10.1016/j.celrep.2013.05.005
    • Burge JA, Hanna MG, Schorge S (2013). Nongenomic actions of progesterone and 17β-estradiol on the chloride conductance of skeletal muscle.. Muscle Nerve, 48(4), 589 - 591. doi:10.1002/mus.23887
    • Nesbitt V, Pitceathly RD, Turnbull DM, Taylor RW, Sweeney MG, Mudanohwo EE, Rahman S, Hanna MG, McFarland R (2013). The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management.. J Neurol Neurosurg Psychiatry, 84(8), 936 - 938. doi:10.1136/jnnp-2012-303528
    • Portaro S, Musumeci O, Rizzo V, Rodolico C, Buccafusca M, Toscano A, Sweeney MG, Hanna MG (2013). Stiffness as a presenting symptom of an odd clinical condition caused by multiple sclerosis and myotonia congenita. Neuromuscular Disorders, 23(1), 52 - 55. doi:10.1016/j.nmd.2012.07.005
    • Machado P, Miller A, Herbelin L, He J, Noel J, Wang Y, McVey AL, Pasnoor M, Gallagher P, Statland J, Brady S, Lu C-H, Kalmar B, Sethi H, Samandouras G, Holton J, Greensmith L, Barohn RJ, Hanna MG, Dimachkie MM (2013). SAFETY AND TOLERABILITY OF ARIMOCLOMOL IN PATIENTS WITH SPORADIC INCLUSION BODY MYOSITIS: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IIA PROOF-OF-CONCEPT TRIAL. ANNALS OF THE RHEUMATIC DISEASES, 72, 164 - 164.
    • Cortese A, Plagnol V, Brady S, Simone R, Lashley T, Acevedo-Arozena A, de Silva R, Greensmith L, Holton J, Hanna MG, Fisher EM, Fratta P (2013). Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.. Neurobiol Aging, , - . doi:10.1016/j.neurobiolaging.2013.12.029
    • Burge JA, Hanna MG, Schorge S (2013). Nongenomic actions of progesterone and 17β-estradiol on the chloride conductance of skeletal muscle.. Muscle & nerve, 48(4), 589 - 591.
    • Turner C, Hanna MG, Hilton-Jones D, Lochmüller H (2013). MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011. Neuromuscular Disorders, 23(12), 1069 - 1080. doi:10.1016/j.nmd.2013.07.006
    • Rajakulendran S, Koltzenburg M, Hanna MG, Roberts J, Stewart H (2013). Deletion of chromosome 12q21 affecting KCNC2 and ATXN7L3B in a family with neurodevelopmental delay and ataxia. Journal of Neurology, Neurosurgery and Psychiatry, 84(11), 1255 - 1257. doi:10.1136/jnnp-2012-304555
    • Fischmann A, Morrow JM, Sinclair CD, Reilly MM, Hanna MG, Yousry T, Thornton JS (2013). Improved anatomical reproducibility in quantitative lower-limb muscle MRI.. J Magn Reson Imaging, , - . doi:10.1002/jmri.24220
    • Tomlinson SE, Rajakulendran S, Tan SV, Graves TD, Bamiou D-E, Labrum RW, Giunti P, Kullmann DM, Hanna MG, Schorge S, Burke D, Sue CM (2013). Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1. Journal of Neurology, Neurosurgery and Psychiatry, 84(10), 1107 - 1112. doi:10.1136/jnnp-2012-304131
    • Machado P, Brady S, Hanna MG (2013). Update in inclusion body myositis.. Curr Opin Rheumatol, 25(6), 763 - 771. doi:10.1097/01.bor.0000434671.77891.9a
    • Spillane J, Fialho D, Hanna MG (2013). Diagnosis of skeletal muscle channelopathies.. Expert Opin Med Diagn, , - . doi:10.1517/17530059.2013.839656
    • Turner C, Hanna MG, Hilton-Jones D, Lochmüller H (2013). MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011. Neuromuscular Disorders, , - . doi:10.1016/j.nmd.2013.07.006
    • Tan SV, Z'graggen WJ, Boërio D, Rayan DR, Norwood F, Ruddy D, Howard R, Hanna MG, Bostock H (2013). Chloride channels in myotonia congenita assessed by velocity recovery cycles.. Muscle Nerve, , - . doi:10.1002/mus.24069
    • Fratta P, Collins T, Pemble S, Nethisinghe S, Devoy A, Giunti P, Sweeney MG, Hanna MG, Fisher EM (2013). Sequencing analysis of the spinal bulbar muscular atrophy CAG expansion reveals absence of repeat interruptions.. Neurobiol Aging, , - . doi:10.1016/j.neurobiolaging.2013.07.015
    • Pfeffer G, Yu-Wai-Man P, Mcfarland R, Turnbull DM, Chinnery PF, Klopstock T, Mootha VK, Suomalainen A, Koene S, Smeitink J, Hirano M, Zeviani M, Bindoff LA, Hanna M, Carelli V, Majamaa K, Horvath R (2013). New treatments for mitochondrial disease - No time to drop our standards. Nature Reviews Neurology, 9(8), 474 - 481. doi:10.1038/nrneurol.2013.129
    • Willis TA, Hollingsworth KG, Coombs A, Sveen ML, Andersen S, Stojkovic T, Eagle M, Mayhew A, de Sousa PL, Dewar L, Morrow JM, Sinclair CD, Thornton JS, Bushby K, Lochmüller H, Hanna MG, Hogrel JY, Carlier PG, Vissing J, Straub V (2013). Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study.. PLoS One, 8(8), e70993 - . doi:10.1371/journal.pone.0070993
    • Hiscock A, Dewar L, Parton M, Machado P, Hanna M, Ramdharry G (2013). Frequency and circumstances of falls in people with inclusion body myositis: a questionnaire survey to explore falls management and physiotherapy provision.. Physiotherapy, , - . doi:10.1016/j.physio.2013.06.002
    • Morrow JM, Matthews E, Raja Rayan DL, Fischmann A, Sinclair CDJ, Reilly MM, Thornton JS, Hanna MG, Yousry TA (2013). Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias. Neuromuscular Disorders, , - .
    • Sarkozy A, Hicks D, Hudson J, Laval SH, Harris E, De Waele L, Guglieri M, Eagle M, Bailey G, Straub V, Bushby K, Lochmüller H, Barresi R, Hilton-Jones D, Deschauer M, Rufibach L, Hwang E, Bashir R, Walter MC, Krause S, Schoser B, van den Bergh P, Illa I, Pénisson-Besnier I, Turnbull D, Gorman GS, Schrank B, Seeger J, Schreiber H, Gläser D, Walters R, Longman C, Norwood F, Winer J, Davies NP, Muntoni F, Hanna M, Parton M, Turner C, Roberts M, Bindoff LA, Brierley C, Cooper RG, Cottrell DA, Gibson A, Hammans S, Jackson AP, Khan A, Lane R, Mcconville J, Mcentagart M, Al-Memar A, Nixon J, Panicker J, Ray P, Petty R, Price CJ, Rakowicz W, Schapira AH, Swingler R, Wagner KR, Maddison P, Shaw PJ (2013). ANO5 Gene Analysis in a Large Cohort of Patients with Anoctaminopathy: Confirmation of Male Prevalence and High Occurrence of the Common Exon 5 Gene Mutation. Human Mutation, 34(8), 1111 - 1118. doi:10.1002/humu.22342
    • Fratta P, Hanna MG, Fisher EM, Sidle K (2013). An unusual presentation for SOD1-ALS: Isolated facial diplegia.. Muscle Nerve, , - . doi:10.1002/mus.23958
    • Trivedi JR, Bundy B, Statland J, Salajegheh M, Rayan DR, Venance SL, Wang Y, Fialho D, Matthews E, Cleland J, Gorham N, Herbelin L, Cannon S, Amato A, Griggs RC, Hanna MG, Barohn RJ, CINCH Consortium (2013). Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.. Brain, 136(Pt 7), 2189 - 2200. doi:10.1093/brain/awt133
    • Pfeffer G, Horvath R, Klopstock T, Mootha VK, Suomalainen A, Koene S, Hirano M, Zeviani M, Bindoff LA, Yu-Wai-Man P, Hanna M, Carelli V, McFarland R, Majamaa K, Turnbull DM, Smeitink J, Chinnery PF (2013). New treatments for mitochondrial disease-no time to drop our standards. Nature Reviews Neurology, , - .
    • Horga A, Rayan DLR, Matthews E, Sud R, Fialho D, Durran SCM, Burge JA, Portaro S, Davis MB, Haworth A, Hanna MG (2013). Prevalence study of genetically defined skeletal muscle channelopathies in England. Neurology, 80(16), 1472 - 1475.
    • Thorne T, Fratta P, Hanna M, Cortese A, Plagnol V, Fisher EMC, Stumpf M (2013). Graphical modelling of molecular networks underlying sporadic inclusion body myositis. Molecular Biosystems, , - .
    • Cortese A, Machado P, Morrow J, Dewar L, Hiscock A, Miller A, Parton M, Hanna MG, Brady S, Hilton-Jones D (2013). Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials. Neuromuscular Disorders, 23(5), 404 - 412. doi:10.1016/j.nmd.2013.02.010
    • Rajakulendran S, Roberts J, Koltzenburg M, Hanna MG, Stewart H (2013). Deletion of chromosome 12q21 affecting KCNC2 and ATXN7L3B in a family with neurodevelopmental delay and ataxia.. J Neurol Neurosurg Psychiatry, 84(11), 1255 - 1257. doi:10.1136/jnnp-2012-304555
    • Cortese A, Machado P, Morrow J, Dewar L, Hiscock A, Miller A, Brady S, Hilton-Jones D, Parton M, Hanna MG (2013). Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials.. Neuromuscul Disord, 23(5), 404 - 412. doi:10.1016/j.nmd.2013.02.010
    • Horga A, Raja Rayan DL, Matthews E, Sud R, Fialho D, Durran SC, Burge JA, Portaro S, Davis MB, Haworth A, Hanna MG (2013). Prevalence study of genetically defined skeletal muscle channelopathies in England.. Neurology, 80(16), 1472 - 1475. doi:10.1212/WNL.0b013e31828cf8d0
    • Smith MD, Seth JH, Hanna MG, Panicker JN (2013). Detrusor overactivity in Becker muscular dystrophy.. Muscle Nerve, 47(3), 464 - 465. doi:10.1002/mus.23623
    • Malik B, Nirmalananthan N, Gray AL, La Spada AR, Hanna MG, Greensmith L (2013). Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.. Brain, 136(Pt 3), 926 - 943. doi:10.1093/brain/aws343
    • Tomlinson SE, Rajakulendran S, Tan SV, Graves TD, Bamiou DE, Labrum RW, Burke D, Sue CM, Giunti P, Schorge S, Kullmann DM, Hanna MG (2013). Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.. J Neurol Neurosurg Psychiatry, 84(10), 1107 - 1112. doi:10.1136/jnnp-2012-304131
    • Pitceathly RDS, Tomlinson SE, Holton JL, Morrow JM, Rahman S, Hanna MG, Hargreaves I, Bhardwaj N, Evans J, Smith C, Fratter C, Woodward CE, Sweeney MG (2013). Distal myopathy with cachexia: An unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase γ mutations. Journal of Neurology, Neurosurgery and Psychiatry, 84(1), 107 - 110. doi:10.1136/jnnp-2012-303232
    • Portaro S, Musumeci O, Rizzo V, Rodolico C, Sweeney MG, Buccafusca M, Hanna MG, Toscano A (2013). Stiffness as a presenting symptom of an odd clinical condition caused by multiple sclerosis and myotonia congenita.. Neuromuscul Disord, 23(1), 52 - 55. doi:10.1016/j.nmd.2012.07.005
    • Jaffer F, Reilly MM, Quinlivan R, Muntoni F, Turner C, Parton M, Lunn M, Hilton-Jones D, Korkodilos M, Hanna MG (2013). Emergency neuromuscular admissions are avoidable: a regional audit of unplanned hospital admissions of neuromuscular patients 2009-2011: final results and recommendations.. J Neurol Neurosurg Psychiatry, 84(11), e2 - . doi:10.1136/jnnp-2013-306573.7

    2012

    • Nesbitt V, Pitceathly R, Cockell S, Poulton J, Rahman S, Hanna M, Turnbull D, McFarland R (2012). The medical research council neuromuscular centre for translational research mitochondrial disease patient cohort study UK: from conceptualisation to utilisation.
    • Horga A, Raja Rayan D, Matthews E, Fialho D, Sud R, Haworth A, Portaro S, Burge J, Davis MB, Hanna MG (2012). Prevalence study of skeletal muscle channelopathies in England.. doi:10.1136/jnnp-2011-301993.56
    • Machado P, Hudson J, Miller A, Morrow J, Parton M, Bushby K, Hanna M (2012). VALOSIN CONTAINING PROTEIN (VCP) AND MYOFIBRILLAR MYOPATHIES (MFM) GENES' MUTATIONS ARE NOT ASSOCIATED WITH SPORADIC INCLUSION BODY MYOSITIS (sIBM). doi:10.1136/jnnp-2011-301993.139
    • Lee HY, Huang Y, Bruneau N, Roll P, Roberson ED, Hermann M, Quinn E, Maas J, Edwards R, Ashizawa T, Baykan B, Bhatia K, Bressman S, Bruno MK, Brunt ER, Caraballo R, Echenne B, Fejerman N, Frucht S, Gurnett CA, Hirsch E, Houlden H, Jankovic J, Lee WL, Lynch DR, Mohamed S, Müller U, Nespeca MP, Renner D, Rochette J, Rudolf G, Saiki S, Soong BW, Swoboda KJ, Tucker S, Wood N, Hanna M, Bowcock A, Szepetowski P, Fu YH, Ptáček LJ (2012). Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.. Cell Rep, 1(1), 2 - 12. doi:10.1016/j.celrep.2011.11.001
    • Rajakulendran S, Kaski D, Hanna MG (2012). Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.. Nat Rev Neurol, 8(2), 86 - 96. doi:10.1038/nrneurol.2011.228
    • Pulkes T, Dejthevaporn C, Papsing C, Apiwattanakul M, Hanna MG (2012). Paroxysmal neuromyotonia: A new sporadic channelopathy. Neuromuscular Disorders, 22(6), 479 - 482. doi:10.1016/j.nmd.2012.01.004
    • Sinclair CD, Morrow JM, Miranda MA, Davagnanam I, Cowley PC, Mehta H, Hanna MG, Koltzenburg M, Yousry TA, Reilly MM, Thornton JS (2012). Skeletal muscle MRI magnetisation transfer ratio reflects clinical severity in peripheral neuropathies.. J Neurol Neurosurg Psychiatry, 83(1), 29 - 32. doi:10.1136/jnnp.2011.246116
    • Rajakulendran S, Stewart H, Koltzenburg M, Hanna MG (2012). DELETION OF THE POTASSIUM CHANNEL GENE KCNC2 IN A FAMILY WITH NEURODEVELOPMENTAL DELAY AND ATAXIA. doi:10.1136/jnnp-2012-304200a.50
    • Miller A, Ahmed M, Hanna MG, Greensmith L (2012). DEVELOPING NEW THERAPEUTIC STRATEGIES FOR INCLUSION BODY MYOSITIS. doi:10.1136/jnnp-2011-301993.140
    • Ricotti V, Scoto M, Mandy WPL, Entwistle K, Robb SA, Mercuri E, Skuse DH, Muntoni F (2012). Neurobehavioural disorders in Duchenne Muscular Dystrophy. doi:10.1016/j.nmd.2012.06.278
    • Gardiner A, Jaffer F, Pittman A, Gibbons V, Wood N, Hanna M, Houlden H (2012). Next Generation Sequencing of Ion Channels in Neurological disorders.
    • Woodward C, Sweeney MG, Pitceathly RDS, Mudanohwo EE, Hughes D, Pittman A, Houlden H, Rahman S, Hanna MG (2012). Next Generation Sequencing as a potential diagnostic tool for mitochondrial DNA diseases.
    • Gibbons V, Labrum RW, Haworth A, Sweeney MG, Wood NW, Houlden H, Hanna MG (2012). Episodic ataxia type 2-mutation analysis and screening recommendations.
    • Gardiner AR, Bhatia KP, Stamelou M, Dale RC, Kurian MA, Schneider SA, Wali GM, Counihan T, Schapira AH, Spacey SD, Valente E-M, Silveira-Moriyama L, Teive HAG, Raskin S, Sander JW, Lees A, Warner T, Kullmann DM, Wood NW, Hanna M, Houlden H (2012). PRRT2 gene mutations From paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. NEUROLOGY, 79(21), 2115 - 2121.
    • Lee H-Y, Huang Y, Bruneau N, Roll P, Roberson EDO, Hermann M, Quinn E, Maas J, Edwards R, Ashizawa T, Baykan B, Bhatia K, Bressman S, Bruno MK, Brunt ER, Caraballo R, Echenne B, Fejerman N, Frucht S, Gurnett CA, Hirsch E, Houlden H, Jankovic J, Lee W-L, Lynch DR, Mohammed S, Mueller U, Nespeca MP, Renner D, Rochette J, Rudolf G, Saiki S, Soong B-W, Swoboda KJ, Tucker S, Wood N, Hanna M, Bowcock AM, Szepetowski P, Fu Y-H, Ptacek LJ (2012). Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions. CELL REPORTS, 1(1), 2 - 12. doi:10.1016/j.celrep.2011.11.001
    • Schottlaender LV, Mencacci N, Koepp M, Hanna M, Hardy J, Lees AJ, Houlden H (2012). Interesting clinical features associated with mutations in the SLC20A2 gene.
    • Pitceathly RDS, Tomlinson SE, Hargreaves I, Bhardwaj N, Holton JL, Evans J, Smith C, Fratter C, Woodward C, Sweeney MG, Hanna MG, Rahman S (2012). NOVEL DOMINANT POLG MUTATIONS CAUSE DISTAL MYOPATHY.
    • Fassone E, Taanman JW, Sweeney MG, Woodward C, Hargreaves IP, Hanna MG, Taylor RW, Duncan AJ, Rahman S (2012). WHOLE EXOME SEQUENCING REVEALS THAT SUBUNIT MUTATIONS ARE PREVALENT IN COMPLEX I DEFICIENT LEIGH SYNDROME.
    • Pitceathly RDS, Murphy SM, Cottenie E, Chalasani A, Sweeney MG, Woodward C, Mudanohwo EE, Hargreaves I, Heales S, Land J, Holton JL, Houlden H, Blake J, Champion M, Flinter F, Robb SA, Page R, Palace J, Crowe C, Longman C, Lunn MP, Rahman S, Reilly MM, Hanna MG (2012). Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. NEUROLOGY, 79(11), 1145 - 1154.
    • Pitceathly RD, Smith C, Fratter C, Alston CL, He L, Craig K, Blakely EL, Evans JC, Taylor J, Shabbir Z, Deschauer M, Pohl U, Roberts ME, Jackson MC, Halfpenny CA, Turnpenny PD, Lunt PW, Hanna MG, Schaefer AM, McFarland R, Horvath R, Chinnery PF, Turnbull DM, Poulton J, Taylor RW, Gorman GS (2012). Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.. Brain, 135(Pt 11), 3392 - 3403. doi:10.1093/brain/aws231
    • Gardiner AR, Bhatia KP, Stamelou M, Dale RC, Kurian MA, Schneider SA, Wali GM, Counihan T, Schapira AH, Spacey SD, Valente EM, Silveira-Moriyama L, Teive HA, Raskin S, Sander JW, Lees A, Warner T, Kullmann DM, Wood NW, Hanna M, Houlden H (2012). PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.. Neurology, 79(21), 2115 - 2121. doi:10.1212/WNL.0b013e3182752c5a
    • Tan SV, Z'graggen WJ, Boërio D, Rayan DL, Howard R, Hanna MG, Bostock H (2012). Membrane dysfunction in Andersen-Tawil syndrome assessed by velocity recovery cycles.. Muscle Nerve, 46(2), 193 - 203. doi:10.1002/mus.23293
    • Korkodilos M, Hajioff S, Gardner C, Overett S, Ibrahim S, Jaffer F, Hanna MG (2012). Audit of unplanned admissions in neuromuscular patients: a collaborative audit.
    • Lee H-Y, Huang Y, Edwards R, Hanna M, Bowcock A, Szepetowski P, Fu Y-H, Ptacek L (2012). Mutations in the Novel Protein PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions.
    • Wang Y, He J, McVey A, Pasnoor M, Gallagher P, Herbelin L, Statland J, Miller A, Greensmith L, Machado P, Hanna M, Barohn R, Dimachkie M (2012). Twelve-Month Change of IBMFRS in the Arimocolomol Inclusion Body Myositis Pilot Study.
    • Brady S, Squier W, Hilton-Jones D, Sewry C, Hanna M, Holton JL (2012). A histological evaluation of protein accumulation in inflammatory myopathies.
    • Rayan DLR, Matthews E, Barreto G, Tan SV, Dewar L, Burge J, Wang Y, Trivedi J, Ciafaloni E, Salajegheh M, Venance S, Meola G, Bundy B, Herbelin L, Statland J, Griggs R, Barohn R, Hanna MG, Grp CINCH (2012). Efficacy of mexiletine in non-dystrophic myotonia: results of an international multi-centred randomised controlled trial.
    • Jaffer F, Graves T, Gibbons V, Gardiner A, Hersheson J, Hanna M, Houlden H (2012). Episodic ataxia: screening candidate genes and genetic analysis of families.
    • Gardiner A, Kullmann D, Wood N, Ptacek L, Houlden H, Hanna M (2012). Episodic muscle and brain channels: Analysis of the PRRT2 gene and screening of a muscle channel panel.
    • Cottenie E, Laura M, Hanna M, Dick D, Blake J, Houlden H, Reilly MM (2012). Genetic analysis of FIG4 in patients with CMT.
    • Pitceathly RDS, Murphy SM, Cottenie E, Chalasani A, Sweeney MG, Woodward C, Mudanohwo EE, Hargreaves I, Heales S, Holton JL, Houlden H, Lunn MP, Rahman S, Reilly MM, Hanna MG (2012). Genetic dysfunction of MT-ATP6 can cause axonal Charcot-Marie-Tooth disease.
    • Baruch N, Duchen M, Hanna MG (2012). Muscle degeneration in ion channel dysfunction.
    • Machado P, Hudson J, Miller A, Morrow J, Parton M, Bushby K, Hanna MG (2012). Myofibrillar myopathies (MFM), valosin containing protein (VCP) and glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) genes' mutations are not associated with sporadic inclusion body myositis (sIBM).
    • Horga A, Rayan DLR, Haworth A, Matthews E, Fialho D, Sud R, Portaro S, Burge JA, Davis MB, Hanna MG (2012). Prevalence study of skeletal muscle channelopathies in England.
    • Burge J, Schorge S, Hanna MG (2012). Progesterone reduces and shifts the voltage dependence of the skeletal muscle chloride conductance.
    • Sinclair CDJ, Morrow JM, Miranda MA, Davagnanam I, Cowley PC, Mehta H, Hanna MG, Koltzenburg M, Yousry TA, Reilly MM, Thornton JS (2012). Skeletal muscle MRI magnetisation transfer ratio reflects clinical severity in peripheral neuropathies. Journal of Neurology, Neurosurgery and Psychiatry, 83(1), 29 - 32.
    • Burge JA, Hanna MG (2012). Novel insights into the pathomechanisms of skeletal muscle channelopathies.. Curr Neurol Neurosci Rep, 12(1), 62 - 69. doi:10.1007/s11910-011-0238-3
    • Sinclair CD, Morrow JM, Hanna MG, Reilly MM, Yousry TA, Golay X, Thornton JS (2012). Correcting radiofrequency inhomogeneity effects in skeletal muscle magnetisation transfer maps.. NMR Biomed, 25(2), 262 - 270. doi:10.1002/nbm.1744
    • Gray A, Nirmalananthan N, Malik B, Dick J, Hanna M, Greensmith L (2012). Targeting the endogenous stress response in a mouse model of SBMA.
    • Morrow J, Sinclair CDJ, Fischmann A, Thornton JS, Yousry TA, Reilly MM, Hanna MG (2012). MRI QUANTIFICATION OF LOWER LIMB MUSCLE FATTY ATROPHY: A POTENTIAL OUTCOME MEASURE IN CHRONIC NEUROMUSCULAR DISEASES. doi:10.1136/jnnp-2011-301993.32
    • Tomlinson SE, Burke D, Bostock H, Hanna MG, Kullmann DM, Grinton B, Scheffer IE, Berkovic SF, Kiernan MC (2012). In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission. Brain, 135(10), 3144 - 3152. doi:10.1093/brain/aws241
    • Machado P, Cortese A, Morrow J, Dewar L, Hiscock A, Miller A, Brady S, Hilton-Jones D, Parton M, Hanna MG (2012). The Natural History of Sporadic Inclusion Body Myositis-an Observational Longitudinal Study..
    • Raheem O, Penttila S, Suominen T, Kaakinen M, Burge J, Haworth A, Sud R, Schorge S, Haapasalo H, Sandell S, Metsikko K, Hanna M, Udd B (2012). New immunohistochemical method for improved myotonia and chloride channel mutation diagnostics. doi:10.1016/j.nmd.2012.06.314
    • Ricotti V, Engledow E, Emmanuel A, Knowles J, Walker D, Giordano P, Simonds A, Hanna M, Quinlivan R (2012). Recurrent pseudo-obstruction and sigmoid volvulus in Duchenne Muscular Dystrophy: A case report. doi:10.1016/j.nmd.2012.06.279
    • Raheem O, Penttilä S, Suominen T, Kaakinen M, Burge J, Haworth A, Sud R, Schorge S, Haapasalo H, Sandell S, Metsikkö K, Hanna M, Udd B (2012). New immunohistochemical method for improved myotonia and chloride channel mutation diagnostics.. Neurology, 79(22), 2194 - 2200. doi:10.1212/WNL.0b013e31827595e2
    • Fratta P, Malik B, Gray A, La Spada A, Hanna MG, Fisher EMC, Greensmith L (2012). FUS is not dysregulated by the spinal bulbar muscular atrophy androgen receptor polyglutamine repeat expansion. Neurobiology of Aging, , - .
    • Statland JM, Bundy BN, Wang Y, Trivedi JR, Raja Rayan D, Herbelin L, Donlan M, McLin R, Eichinger KJ, Findlater K, Dewar L, Pandya S, Martens WB, Venance SL, Matthews E, Amato AA, Hanna MG, Griggs RC, Barohn RJ, CINCH Consortium (2012). A quantitative measure of handgrip myotonia in non-dystrophic myotonia.. Muscle Nerve, 46(4), 482 - 489. doi:10.1002/mus.23402
    • Raja Rayan DL, Haworth A, Sud R, Matthews E, Fialho D, Burge J, Portaro S, Schorge S, Tuin K, Lunt P, McEntagart M, Toscano A, Davis MB, Hanna MG (2012). A new explanation for recessive myotonia congenita: exon deletions and duplications in CLCN1.. Neurology, 78(24), 1953 - 1958. doi:10.1212/WNL.0b013e318259e19c
    • Pitceathly RD, Rahman S, Hanna MG (2012). Single deletions in mitochondrial DNA--molecular mechanisms and disease phenotypes in clinical practice.. Neuromuscul Disord, 22(7), 577 - 586. doi:10.1016/j.nmd.2012.03.009
    • Matthews E, Plotz PH, Portaro S, Parton M, Elliott P, Humbel RL, Holton JL, Keegan BM, Hanna MG (2012). A case of necrotizing myopathy with proximal weakness and cardiomyopathy.. Neurology, 78(19), 1527 - 1532. doi:10.1212/WNL.0b013e3182553baa
    • Trivedi J, Bundy B, Rayan DR, Salajegheh M, Statland J, Venance S, Wang Y, Fialho D, Hart K, Gorham N, Herbelin L, Amato A, Hanna M, Griggs R, Barohn R (2012). Clinical and Molecular Characterization of Non-Dystrophic Myotonia.
    • Graves T, Fialho D, Smith S, Cha Y-H, Amato A, Griggs R, Bundy B, Jen J, Baloh R, Hanna M (2012). EEG Abnormalities in the Episodic Ataxias.
    • Graves T, Cha Y-H, Hahn A, Barohn R, Amato A, Griggs R, Bundy B, Jen J, Baloh R, Hanna M (2012). Episodic Ataxia Type 1: Characterization of the Disease and Its Effect on Quality of Life.
    • Statland J, Salajegheh M, Bundy B, Wang Y, Rayan DR, Trivedi J, Sansone V, Venance S, Ciafaloni E, Matthews E, Meola G, Zanolini A, Ciocca M, Herbelin L, Griggs R, Barohn R, Hanna M, Invest CC (2012). Phase II Therapeutic Trial of Mexiletine in Non-Dystrophic Myotonia: Secondary Outcomes Show Improvement in Symptoms and Signs of Myotonia.
    • Cortese A, Machado P, Miller A, Brady S, Hilton-Jones D, Morrow J, Hiscock A, Dewar E, Parton M, Hanna M (2012). CLINICAL FEATURES AND CLINICAL COURSE OF SPORADIC INCLUSION BODY MYOSITIS (IBM): A PROSPECTIVE COHORT STUDY: IBM-NET. doi:10.1136/jnnp-2011-301993.19
    • Piceathly RDS, Smith C, Fratter C, Blakely EL, Alston CL, Deschauer M, Horvath R, Hanna MG, Chinnery PF, Turnbull DM, Poulton J, Taylor RW, Gorman GS (2012). Expanding the phenotypic and genotypic spectrum of adult RRM2B-related mitochondrial disease.
    • Hiscock A, Dewar L, Parton M, Machado P, Hanna M, Ramdharry G (2012). Frequency and circumstances of falls in people with Inclusion Body Myositis.
    • Rayan DR, Haworth A, Sud R, McCall S, Tan SV, Durran S, Davis M, Hanna MG (2012). IDENTIFYING THE CAUSE OF PHENOTYPIC VARIABILITY IN A FAMILY WITH NON-DYSTROPHIC MYOTONIA. doi:10.1136/jnnp-2011-301993.57
    • Rayan DR, Barohn RJ, Bundy B, Wang Y, Herbelin L, Trivedi J, Venance S, Meola G, Griggs RC, Hanna MG, Grp CINCHS (2012). MEXILETINE IS AN EFFECTIVE TREATMENT IN NON-DYSTROPHIC MYOTONIA. doi:10.1136/jnnp-2011-301993.20
    • Rayan DR, Haworth A, Sud R, Matthews E, Fialho D, Burge J, Portaro S, Toscano A, Davis MD, Hanna MG (2012). SKELETAL MUSCLE CHLORIDE CHANNEL GENE (CLCN1) COPY NUMBER VARIATION CAN CAUSE MYOTONIA CONGENITA. doi:10.1136/jnnp-2011-301993.21
    • Ahmed M, Miller A, Hanna MG, Greensmith L (2012). Investigating the effects of pharmacological up-regulation of the heat shock response in an in-vitro model of sporadic inclusion body myositis.
    • Morrow JM, Sinclair CDJ, Fischmann A, Thornton JS, Reilly MM, Hanna MG, Yousry TA (2012). MRI quantification of abnormal muscle water distribution in chronic neuromuscular diseases: a sensitive biomarker.
    • Sinclair CD, Morrow JM, Fischmann A, Hanna MG, Reilly MM, Yousry TA, Golay X, Thornton JS (2012). Novel muscle fat-fraction MRI metrics for quantifying neuromuscular pathology.
    • Cortese A, Machado P, Morrow J, Dewar L, Hiscock A, Miller A, Brady S, Hilton-Jones D, Parton M, Hanna MG (2012). The natural history of sporadic inclusion body myositis: data from the IBM-Net prospective cohort study.

    2011

    • Guergueltcheva V, Müller JS, Dusl M, Senderek J, Oldfors A, Lindbergh C, Maxwell S, Colomer J, Mallebrera CJ, Nascimento A, Vilchez JJ, Muelas N, Kirschner J, Nafissi S, Kariminejad A, Nilipour Y, Bozorgmehr B, Najmabadi H, Rodolico C, Sieb JP, Schlotter B, Schoser B, Herrmann R, Voit T, Steinlein OK, Najafi A, Urtizberea A, Soler DM, Muntoni F, Hanna MG, Chaouch A, Straub V, Bushby K, Palace J, Beeson D, Abicht A, Lochmüller H (2011). Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.. J Neurol, , - . doi:10.1007/s00415-011-6262-z
    • Scoto M, Cirak S, Feng L, Manzur AY, Robb S, Main M, Sewry C, Mercuri E, Muntoni F, Mein R, Abbs S, Childs A-M, Quinlivan RM, Roper H, Jones DH, Longman C, Chow G, Pane M, Hanna MG, Bushby K (2011). SEPN1-related myopathies: Clinical course in a large cohort of patients. Neurology, 76(24), 2073 - 2078. doi:10.1212/WNL.0b013e31821f467c
    • Fratter C, Raman P, Alston CL, Blakely EL, Craig K, Smith C, Evans J, Seller A, Czermin B, Hanna MG, Poulton J, Brierley C, Staunton TG, Turnpenny PD, Schaefer AM, Chinnery PF, Horvath R, Turnbull DM, Gorman GS, Taylor RW (2011). RRM2B MUTATIONS ARE FREQUENT IN FAMILIAL PEO WITH MULTIPLE mtDNA DELETIONS. NEUROLOGY, 76(23), 2032 - 2034. doi:10.1212/WNL.0b013e31821e558b
    • Pitceathly RD, Fassone E, Taanman JW, Sadowski M, Fratter C, Mudanohwo EE, Woodward CE, Sweeney MG, Holton JL, Hanna MG, Rahman S (2011). Kearns-Sayre syndrome caused by defective R1/p53R2 assembly.. J Med Genet, 48(9), 610 - 617. doi:10.1136/jmg.2010.088328
    • Muller T, Cirak S, Parton M, Lunn M, Hanna MG, Muntoni F (2011). An integrative database for clinical and research studies in neuromuscular diseases.
    • Rayan DLR, Matthews E, Barreto G, Tan SV, Dewar L, Burge J, Barohn R, Hanna MG, CINCH Grp (2011). Assessing the efficacy of Mexiletine in UK patients with non-dystrophic myotonia.
    • Duchen MR, Heath K, Baruch NB, Hanna MG, Muntoni F (2011). Dysregulation of calcium and mitochondrial function as potential therapeutic targets in muscle disease.
    • Durran S, Matthews E, Rayan DLR, Sud R, Polke J, Haworth A, Holton JL, Sweeney MG, Hanna MG (2011). Genetic heterogeneity and mechanisms of phenotypic variability in human skeletal muscle channelopathies - a new S4 mutation not associated with HypoPP.
    • Rayan DLR, Matthews E, Rajakulendran S, Barreto G, Tan SV, Dewar L, Burge J, Griggs RC, Barohn R, Hanna MG, CINCH Grp (2011). Genotype-phenotype correlation and longitudinal three year natural history study in the non-dystrophic myotonias in the UK.
    • Brady S, Squier W, Hanna MG, Hilton-Jones D, Sewry C, Holton JL (2011). Inclusion body myositis: a diagnostic challenge.
    • Scoto M, Cirak S, Mein R, Feng L, Manzur AY, Robb S, Childs AM, Quinlivan RM, Roper H, Hilton-Jones D, Longman C, Chow G, Pane M, Main M, Hanna MG, Bushby K, Sewry C, Abbs S, Mercuri E, Muntoni F (2011). SEPN1 related myopathies: Clinical course in a large cohort of patients.
    • Miller A, Ahmed M, Hanna MG, Greensmith L (2011). The effects of arimoclomol on pathological outcome measures of inclusion body myositis in vitro.
    • Nesbitt V, Pitceathly RDS, Rahman S, Poulton J, Turnbull DM, Hanna MG, McFarland R (2011). The MRC Centre for Translational Research in Neuromuscular Disease: Mitochondrial Disease Patient Cohort Study UK.
    • Pitceathly RDS, He J, Foley AR, Muntoni F, Pearson N, Hanna MG (2011). Whole genome analysis in a family with dominant muscle disease.
    • Tan SV, Matthews E, Barber M, Burge JA, Rajakulendran S, Fialho D, Sud R, Haworth A, Koltzenburg M, Hanna MG (2011). Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.. Ann Neurol, 69(2), 328 - 340. doi:10.1002/ana.22238
    • Portaro S, Sweeney MG, Matthews E, Sud R, Musumeci O, Rodolico C, Vita G, Toscano A, Hanna M (2011). Clinical and molecular genetic studies of a cohort of Italian patients with muscle channelopathies.
    • Pitceathly RDS, Fassone E, Taanman JW, Sadowski M, Fratter C, Mudanohwo EE, Woodward CE, Sweeney MG, Holton JL, Hanna MG, Rahman S (2011). KEARNS-SAYRE SYNDROME CAUSED BY MUTATIONS IN THE NUCLEAR RRM2B GENE.
    • Matthews E, Manzur AY, Sud R, Muntoni F, Hanna MG (2011). Stridor as a neonatal presentation of skeletal muscle sodium channelopathy.. Arch Neurol, 68(1), 127 - 129. doi:10.1001/archneurol.2010.347
    • Sinclair CD, Miranda MA, Cowley P, Morrow JM, Davagnanam I, Mehta H, Hanna MG, Koltzenburg M, Reilly MM, Yousry TA, Thornton JS (2011). MRI shows increased sciatic nerve cross sectional area in inherited and inflammatory neuropathies.. J Neurol Neurosurg Psychiatry, 82(11), 1283 - 1286. doi:10.1136/jnnp.2010.211334
    • Matthews E, Portaro S, Ke Q, Sud R, Haworth A, Davis MB, Griggs RC, Hanna MG (2011). Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.. Neurology, 77(22), 1960 - 1964. doi:10.1212/WNL.0b013e31823a0cb6
    • Matthews E, Miller JA, MacLeod MR, Ironside J, Ambler G, Labrum R, Sud R, Holton JL, Hanna MG (2011). Sodium and chloride channelopathies with myositis: coincidence or connection?. Muscle Nerve, 44(2), 283 - 288. doi:10.1002/mus.22120
    • Rajakulendran S, Parton M, Holton JL, Hanna MG (2011). Clinical and pathological heterogeneity in late-onset partial merosin deficiency.. Muscle Nerve, 44(4), 590 - 593. doi:10.1002/mus.22196
    • Willis TA, Hollingsworth KG, Sveen ML, Morrow J, Vandenheede J, Strojkovic T, Eagle M, Mayhew A, Bushby K, Lochmuller H, Hanna M, Vissing J, Straub V (2011). Quantitative MRI in LGMD2I; a longitudinal study. doi:10.1016/j.nmd.2011.06.845
    • Fratter C, Raman P, Alston CL, Blakely EL, Craig K, Smith C, Evans J, Seller A, Czermin B, Pitceathly RDS, Hanna MG, Poulton J, Brierley C, Staunton TG, Tumpenny PD, Schaefer AM, Chinnery PF, Horvath R, Tumbull DM, Gorman GS (2011). Dominant and recessive RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions.
    • Morrow JM, Dewar EL, Ramdharry GM, Laura M, Yousry TA, Hanna MG, Reilly MM (2011). ISOMETRIC AND ISOKINETIC LOWER LIMB STRENGTH IN CHARCOT-MARIE-TOOTH DISEASE 1A.
    • Sinclair CDJ, Morrow JM, Hanna MG, Reilly MM, Yousry TA, Golay X, Thornton JS (2011). Improved magnetization transfer MRI of skeletal muscle in myopathy and neuropathy.
    • Miller A, Machado P, Morrow JM, Hiscock A, Dewar L, Brady S, Hilton-Jones D, Hanna MG, Parton M (2011). The natural history of sporadic inclusion body myositis: development of an electronic database IBMnet.
    • Pitceathly RDS, Fassone E, Taanman JW, Sadowski M, Fratter C, Mudanohwo EE, Woodward CE, Sweeney MG, Holton JL, Hanna MG, Rahman S (2011). Kearns-Sayre syndrome caused by defective R1/p53R2 assembly. J MED GENET, 48(9), 610 - 617. doi:10.1136/jmg.2010.088328
    • Statland JM, Wang Y, Richesson R, Bundy B, Herbelin L, Gomes J, Trivedi J, Venance S, Amato A, Hanna M, Griggs R, Barohn RJ, Consortium, C (2011). AN INTERACTIVE VOICE RESPONSE DIARY FOR PATIENTS WITH NON-DYSTROPHIC MYOTONIA. MUSCLE NERVE, 44(1), 30 - 35. doi:10.1002/mus.22007
    • Sultan SM, Allen E, Cooper RG, Agarwal S, Kiely P, Oddis CV, Vencovsky J, Lundberg IE, Dastmalchi M, Hanna MG, Isenberg DA (2011). Interrater reliability and aspects of validity of the myositis damage index.. Ann Rheum Dis, 70(7), 1272 - 1276. doi:10.1136/ard.2010.142117
    • Machado P, Miller A, Parton M, Dewar L, Holton JL, Dimachkie M, Herbelir L, Greensmith L, Barohn R, Hanna MG (2011). A randomised, double-blinded, placebo-controlled pilot study assessing the safety and tolerability of Arimoclomol in sporadic inclusion body myositis (IBM).
    • Ahmed M, Miller A, Hanna MG, Greensmith L (2011). Investigating the effects of pharmacological up-regulation of the heat shock response on protein degradation pathways in an in-vitro model of sporadic inclusion body myositis.
    • Nesbitt V, Pitceathly RDS, Rahman S, Hanna MG, McFarland R, Turnbull DM (2011). A3243G-more than just MELAS!.
    • Willis T, Hollingsworth KG, Sveen ML, Morrow JM, Sinclair CDJ, Thornton JS, Vandenheede J, Strojkovic T, Eagle M, Mayhew A, Bushby K, Lochmuller H, Hanna MG, Vissing J, Carliers P, Straub V (2011). Assessing muscle pathology by MRI in LGMD2I.
    • Morrow JM, Matthews E, Rayan DLR, Amer I, Fischmann A, Sinclair CDJ, Thornton JS, Reilly MM, Yousry TA, Hanna MG (2011). Magnetic resonance imaging in the non-dystrophic myotonias.
    • Sinclair CDJ, Morrow JM, Fischmann A, Hanna MG, Reilly MM, Yousry TA, Golay X, Thornton JS (2011). MRI shows increased tibial nerve size in CMT1A.
    • Sinclair CDJ, Morrow JM, Fischmann A, Hanna MG, Reilly MM, Yousry TA, Golay X, Thornton JS (2011). Skeletal muscle MRI-determined fat fraction and myometric strength in inclusion body myositis and Charcot-Marie-Tooth disease Type 1A.
    • Fratter C, Raman P, Alston C, Blakely EL, Craig K, Smith C, Evans J, Seller A, Czermin B, Hanna MG, Poulton J, Brierley C, Staunton TG, Turnpenny PD, Schaefer AM, Chinnery PF, Horvath R, Turnbull DM, Gorman GS, Taylor RW (2011). Dominant and recessive RRM2B mutations cause familial PEO and multiple mtDNA deletions in muscle.
    • Burge J, Horga A, Griggs RC, Hanna MG, HYP HOP Investigators (2011). Double-blind, placebo-controlled, parallel group, phase Ill study comparing dichlorphenamide vs. placebo for the treatment of periodic paralysis (HYP HOP trial).
    • Rayan DLR, Rajakulendran S, Barreto G, Tan SV, Dewar L, Griggs RC, Hanna MG, CINCH Grp (2011). Genotype-phenotype correlation and longitudinal study of Andersen-Tawil Syndrome in the UK.
    • Rayan DLR, Haworth A, Sud R, Burge J, Portaro S, Toscano A, Hanna MG (2011). Large scale chloride channel gene DNA rearrangements are an important cause of recessive myotonia congenita - implications for diagnostic screening.
    • Gray A, Malik B, Montague K, Dick J, Hanna MG, Greensmith L (2011). Investigating pathophysiology and therapeutic strategies in a mouse model of spinal and bulbar muscular atrophy (SBMA).
    • Spillane JE, Hanna MG, Kullmann DM (2011). Synaptic mechanisms in P/Qdeficient neuromuscular junctions.
    • Becker EB, Fogel BL, Rajakulendran S, Dulneva A, Hanna MG, Perlman SL, Geschwind DH, Davies KE (2011). Candidate screening of the TRPC3 gene in cerebellar ataxia.. Cerebellum, 10(2), 296 - 299. doi:10.1007/s12311-011-0253-6
    • Malik B, Nirmalananthan N, Bilsland LG, La Spada AR, Hanna MG, Schiavo G, Gallo JM, Greensmith L (2011). Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.. Hum Mol Genet, 20(9), 1776 - 1786. doi:10.1093/hmg/ddr061
    • Burge J, Hanna MG (2011). Muscle Channelopathies. Neuromuscular Disorders, , 96 - 102. doi:10.1002/9781119973331.ch13
    • Statland J, Wang Y, Bundy B, Trivedi J, Herbelin L, Pandya S, Martens W, Venance S, Amato A, Hanna M, Griggs R, Barohn R (2011). A Quantitative Measure of Handgrip Myotonia in Patients with Non-Dystrophic Myotonia.
    • Tan CD, Hanna M, Rodriguez ER (2011). Immunohistochemical Evaluation of Amyloidosis in Endomyocardial Biopsies.
    • Forrest KML, Al-Sarraj S, Sewry C, Buk S, Tan SV, Pitt M, Durward A, McDougall M, Irving M, Hanna MG, Matthews E, Sarkozyi A, Hudson J, Barresi R, Bushby K, Jungbluth H, Wraige E (2011). Infantile onset myofibrillar myopathy due to recessive CRYAB mutations. NEUROMUSCULAR DISORD, 21(1), 37 - 40. doi:10.1016/j.nmd.2010.11.003
    • Morrow JM, Sinclair CDJ, Fischmann A, Thornton JS, Laura M, Yousry TA, Hanna MG, Reilly MM (2011). QUANTITATIVE MAGNETIC RESONANCE IMAGING OF MUSCLE IN CHARCOT-MARIE-TOOTH DISEASE 1A-A POTENTIAL OUTCOME MEASURE.

    2010

    • Willis TA, Hollingsworth KG, Sveen ML, Morrow J, Vandenheede J, Mayhew A, Eagle M, Bushby K, Lochmuller H, Hanna M, Vissing J, Carlier P, Straub V (2010). Assessing muscle pathology by MRI in LGMD2I. doi:10.1016/j.nmd.2010.07.222
    • Hilton-Jones D, Miller A, Parton M, Holton J, Hanna MG, Sewry C (2010). Inclusion body myositis. MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008. Neuromuscular Disorders, 20(2), 142 - 147. doi:10.1016/j.nmd.2009.11.003
    • Rajakulendran S, Kuntzer T, Dunand M, Yau SC, Ashton EJ, Storey H, McCauley J, Abbs S, Thonney F, Leturcq F, Lobrinus JA, Yousry T, Farmer S, Holton JL, Hanna MG (2010). Marked hemiatrophy in carriers of Duchenne muscular dystrophy.. Arch Neurol, 67(4), 497 - 500. doi:10.1001/archneurol.2010.58
    • Rayan DR, Matthews E, Barreto G, Tan SV, Dewar L, Burge J, Hanna MG (2010). Double-blind placebo controlled cross-over study to investigate the efficacy of mexiletine in patients with non-dystrophic myotonia in the UK.
    • Ahmed M, Miller AD, Hanna MG, Greensmith L (2010). Heat shock protein induction as a therapeutic strategy for inclusion body myositis.
    • Pitceathly RDS, Nesbitt V, Rahman S, McFarland R, Hanna MG, Turnbull DM (2010). MRC mitochondrial cohort study: development of a UK database.
    • Pitceathly RDS, Woodward CE, Mudanohwo EE, Sweeney MG, Davis MB, Hanna MG, Rahman S (2010). Non-invasive diagnosis of single deletion disorders in children with suspected mitochondrial disease.
    • Dewar L, Matthews E, Bahlke G, Hanna MG (2010). Quantification of grip myotonia using a novel accelerometer device: a pilot study.
    • Rajakulendran S, Matthews E, Tan SV, Dewar L, Griggs RC, Hanna MG, CINCH Grp (2010). The genetic skeletal muscle channelopathies: genotype-phenotype correlation and longitudinal studies.
    • Matthews E, Sud R, Labrum R, Strycharczuk L, Sinclair CDJ, Yousry TA, Hanna MG (2010). Using MRI as a diagnostic tool in the skeletal muscle channelopathies.
    • Rajakulendran S, Graves TD, Labrum RW, Kotzadimitriou D, Eunson L, Davis MB, Davies R, Wood NW, Kullmann DM, Hanna MG, Schorge S (2010). Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.. J Physiol, 588(Pt 11), 1905 - 1913. doi:10.1113/jphysiol.2009.186437
    • Tomlinson S, Burke D, Hanna M, Koltzenburg M, Bostock H (2010). In vivo assessment of HCN channel current (I(h)) in human motor axons.. Muscle & Nerve, 41(2), 247 - 256. doi:10.1002/mus.21482
    • Zhou H, Lillis S, Loy RE, Ghassemi F, Rose MR, Norwood F, Mills K, Al-Sarraj S, Lane RJ, Feng L, Matthews E, Sewry CA, Abbs S, Buk S, Hanna M, Treves S, Dirksen RT, Meissner G, Muntoni F, Jungbluth H (2010). Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.. Neuromuscul Disord, 20(3), 166 - 173. doi:10.1016/j.nmd.2009.12.005
    • Rajakulendran S, Schorge S, Kullmann DM, Hanna MG (2010). Dysfunction of the Ca(V)2.1 calcium channel in cerebellar ataxias.. F1000 Biol Rep, 2, - . doi:10.3410/B2-4
    • Matthews E, Fialho D, Tan SV, Venance SL, Cannon SC, Sternberg D, Fontaine B, Amato AA, Barohn RJ, Griggs RC, Hanna MG, CINCH Investigators (2010). The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.. Brain, 133(Pt 1), 9 - 22. doi:10.1093/brain/awp294
    • Sewry CA, Holton JH, Dick DJ, Jacques TS, Muntoni F, Hanna MG (2010). Zebra body myopathy resolved.
    • Portaro S, Matthews E, Sud R, Davis MB, Hanna MG (2010). Acetazolamide response in patients affected by hypokalemic periodic paralysis.
    • Zuberi SM, Eunson LH, Spauschus A, De Silva R, Tolmie J, Wood NW, McWilliam RC, Stephenson JB, Kullmann DM, Hanna MG (2010). A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy (vol 122, pg 817, 1999). BRAIN, 133, 1569 - 1569. doi:10.1093/brain/awn181
    • Carecchio M, Rahman S, Hanna MG, Heales S, Hargreaves I, Land J, Bhatia K (2010). Parkinsonism, multiple lipomas and hearing impairment in a patient with reduced activity of mitochondrial respiratory chain complexes II plus III.
    • Schorge S, Matthews E, Kullmann DM, Hanna MG (2010). VOLTAGE SENSOR CHARGE LOSS ACCOUNTS FOR MOST CASES OF HYPOKALEMIC PERIODIC PARALYSIS Reply. NEUROLOGY, 74(3), 269 - 270.
    • Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM (2010). Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease (vol 12, pg 114, 2010). EUROPEAN JOURNAL OF HEART FAILURE, 12(9), 1017 - 1017. doi:10.1093/eurjhf/hfq143
    • Tomlinson SE, Tan SV, Kullmann DM, Griggs RC, Burke D, Hanna MG, Bostock H (2010). Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.. Brain, 133(Pt 12), 3530 - 3540. doi:10.1093/brain/awq318
    • Rajakulendran S, Labrum RW, Graves TD, Tomlinson S, Eunson LH, Davis MB, Schorge S, Kullmann DM, Hanna MG (2010). PAW31 Clinical and genetic spectrum of the episodic ataxias: the UK perspective.. J Neurol Neurosurg Psychiatry, 81(11), e32 - . doi:10.1136/jnnp.2010.226340.59
    • Rajakulendran S, Pitceathly RD, Warren J, Woodward C, Sweeney MG, Hargreaves I, Fratter C, Heales S, Taylor R, Holton JL, Rahman S, Hanna MG (2010). POG04 Multiple mitochondrial DNA deletions, cyclooxygenase-negative fibres and slowly progressive cognitive decline with psychiatric features.. doi:10.1136/jnnp.2010.226340.126
    • Rajakulendran S, Matthews E, Graves TD, Tan SV, Dewar L, Griggs RC, Hanna MG (2010). POG07 Natural history trials of neurological channelopathies.. J Neurol Neurosurg Psychiatry, 81(11), e49 - . doi:10.1136/jnnp.2010.226340.129
    • Pitceathly R, Rahman S, Maritz C, Hanna MG, Lachmann R, Murphy E (2010). PONM13 Fatty acid oxidation disorders in adults: a potentially treatable cause of muscle disease.. doi:10.1136/jnnp.2010.226340.186
    • Miller A, Ahmed M, Hanna MG, Greensmith L (2010). PONM17 Augmentation of the heat shock response in an in vitro model of sporadic inclusion body myositis.. J Neurol Neurosurg Psychiatry, 81(11), e64 - . doi:10.1136/jnnp.2010.226340.190
    • Graves T, Phadke R, Holton JL, Hanna MG, Rahman S, Bhardwaj N (2010). PONM21 Electron microscopy does not add to the diagnostic accuracy of muscle biopsy for suspected mitochondrial disease. doi:10.1136/jnnp.2010.226340.194
    • Pitceathly R, McFarland R, Nesbitt V, Rahman S, Hanna MG, Turnbull DM (2010). PORT03 MRC mitochondrial cohort study: development of a UK database.. doi:10.1136/jnnp.2010.226340.198
    • Pitceathly RDS, Holton JL, Hargreaves I, Heales S, Woodward C, Sweeney MG, Davis MB, Evans J, Smith C, Fratter C, Rahman S, Hanna MG (2010). Novel POLG mutation causing distal myopathy and cachexia.
    • Rajakulendran S, Tan SV, Hanna MG (2010). Muscle weakness, palpitations and a small chin: the Andersen-Tawil syndrome.. Pract Neurol, 10(4), 227 - 231. doi:10.1136/jnnp.2010.217794
    • Graves TD, Rajakulendran S, Zuberi SM, Morris HR, Schorge S, Hanna MG, Kullmann DM (2010). Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.. Neurology, 75(4), 367 - 372. doi:10.1212/WNL.0b013e3181ea9ee3
    • Limongelli G, Rahman S, Pitceathly RDS, Hanna MG, Elliott PM (2010). Cardiac manifestations of mitochondrial disorders reply. EUR J HEART FAIL, 12(6), 637 - 638. doi:10.1093/eurjhf/hfq046
    • Fratter C, Gorman GS, Stewart JD, Buddles M, Smith C, Evans J, Seller A, Poulton J, Roberts M, Hanna MG, Rahman S, Omer SE, Klopstock T, Schoser B, Kornblum C, Czermin B, Lecky B, Blakely EL, Craig K, Chinnery PF, Turnbull DM, Horvath R, Taylor RW (2010). The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. NEUROLOGY, 74(20), 1619 - 1626.
    • Miller AD, Ahmed M, Hanna MG, Greensmith L (2010). Augmentation of the heat shock response in an in vitro model of sporadic inclusion body myositis.
    • Rajakulendran S, Parton M, Holton JL, Hanna MG (2010). Clinical and pathological heterogeneity in partial merosin deficiency.
    • Parton M, Hanna MG, Miller AD, Morrow JM (2010). IBM-Net: a clinical database of inclusion body myositis patients.
    • Sinclair CDJ, Morrow JM, Yousry TA, Reilly MM, Hanna MG, Golay X, Thornton JS (2010). Inter-scan reproducibility of quantitative neuromuscular MRI.
    • Sinclair CDJ, Miranda MA, Cowley P, Morrow JM, Davagnanam I, Mehta H, Hanna MG, Koltzenburg M, Reilly MM, Yousry TA, Thornton JS (2010). Magnetic resonance imaging and sciatic nerve cross-sectional area in inherited and inflammatory neuropathies.
    • Pitceathly RDS, Holton JL, Miller JAL, Quinlivan R, Hanna MG (2010). The expanding histopathological profile of the myofibrillar myopathies.
    • Matthews E, Hanna MG (2010). Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?. J Physiol, 588(Pt 11), 1879 - 1886. doi:10.1113/jphysiol.2009.186627
    • Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM (2010). Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur.J.Heart Fail., 12(2), 114 - 121.
    • Raja Rayan DL, Hanna MG (2010). Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.. Curr Opin Neurol, 23(5), 466 - 476. doi:10.1097/WCO.0b013e32833cc97e

    2009

    • Labrum RW, Rajakulendran S, Graves TD, Eunson LH, Bevan R, Sweeney MG, Hammans SR, Tubridy N, Britton T, Carr LJ, Ostergaard JR, Kennedy CR, Al-Memar A, Kullmann DM, Schorge S, Temple K, Davis MB, Hanna MG (2009). Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing. Journal of Medical Genetics, 46(11), 786 - 791. doi:10.1136/jmg.2009.067967
    • Labrum R, Rajakulendran S, Sweeney MG, Bevan R, Hanna MG, Davis MB (2009). Screening for mutations causing episodic ataxia type 1 (EA1) and 2 (EA2).
    • Sweeney M, Woodward CE, Mudanohwo EE, Rahman S, Hanna MG, Davis MB (2009). Urine epithelial cells as an alternative to muscle biopsies in the detection of mitochondrial DNA mutations.
    • Sewry CA, Holton J, Dick DJ, Jacques T, Muntoni F, Hanna M (2009). Zebra body myopathy resolved. doi:10.1016/j.nmd.2009.06.292
    • Trender-Gerhard I, Sweeney MG, Schwingenschuh P, Mir P, Edwards MJ, Gerhard A, Polke JM, Hanna MG, Davis MB, Wood NW, Bhatia KP (2009). Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. Journal of Neurology, Neurosurgery and Psychiatry, 80(8), 839 - 845. doi:10.1136/jnnp.2008.155861
    • Matthews E, Labrum R, Sweeney MG, Sud R, Haworth A, Chinnery PF, Meola G, Schorge S, Kullmann DM, Davis MB, Hanna MG (2009). Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology, 72(18), 1544 - 1547. doi:10.1212/01.wnl.0000342387.65477.46
    • Healy DG, Goadsby PJ, Kitchen ND, Yousry T, Hanna MG (2009). Spontaneous intracranial hypotension, hygromata and haematomata.. BMJ Case Rep, 2009, bcr2007132019 - . doi:10.1136/bcr.2007.132019
    • Tomlinson SE, Tan SV, Kullmann DM, Burke D, Hanna MG, Bostock H (2009). Nerve Excitability Measurements Can Distingush Genetic Channelopathies in the Episodic Ataxias.
    • Heeroma JH, Henneberger C, Rajakulendran S, Hanna MG, Schorge S, Kullmann DM (2009). Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release. Disease Models and Mechanisms, 2(11-12), 612 - 619. doi:10.1242/dmm.003582
    • Rajakulendran S, Graves T, Kullmann D, Schorge S, Hanna M (2009). Variation in CACNA1A associated with episodic ataxia and epilepsy.
    • Tomlinson SE, Hanna MG, Kullmann DM, Tan SV, Burke D (2009). Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo.. Clin Neurophysiol, 120(10), 1768 - 1776. doi:10.1016/j.clinph.2009.07.003
    • Rajakulendran S, Tan SV, Matthews E, Tomlinson SE, Labrum R, Sud R, Kullmann DM, Schorge S, Hanna MG (2009). A patient with episodic ataxia and paramyotonia congenita due to mutations in kcna1 and scn4a. Neurology, 73(12), 993 - 995. doi:10.1212/WNL.0b013e3181b87959
    • Fratter C, Gorman G, Stewart JD, Buddles M, Smith C, Evans J, Seller A, Poulton J, Roberts M, Hanna MG, Rahman S, Omer SE, Klopstock T, Schoser B, Kornblum C, Lecky B, Chinnery PF, Turnbull DM, Horvath R, Taylor RW (2009). Autosomal dominant Progressive External Ophthalmoplegia (adPEO) due to mutations in the PEO1 gene: A clinical, histochemical and molecular survey of 33 patients. doi:10.1016/j.nmd.2009.06.062
    • Rahman S, Hanna MG (2009). Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases. Journal of Neurology, Neurosurgery and Psychiatry, 80(9), 943 - 953. doi:10.1136/jnnp.2008.158279
    • Rahman S, Hanna MG (2009). Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases. , 80(9), 943 - 953.
    • Tomlinson SE, Tan SV, Kullmann DM, Burke D, Hanna MG, Bostock H (2009). AXONAL EXCITABILITY CHANGES IN GENETIC NEURONAL ION CHANNEL DISORDERS.
    • Meola G, Hanna MG, Fontaine B (2009). Diagnosis and new treatment in muscle channelopathies. J NEUROL NEUROSUR PS, 80(4), 360 - 365. doi:10.1136/jnnp.2008.164046
    • Machado P, Miller A, Holton J, Hanna M (2009). Sporadic inclusion body myositis: an unsolved mystery. Acta Reumatologica Portuguesa, 34(2A), 161 - 182.
    • Stewart JD, Tennant S, Powell H, Pyle A, Blakely EL, He L, Hudson G, Roberts M, du Plessis D, Gow D, Mewasingh LD, Hanna MG, Omer S, Morris AA, Roxburgh R, Livingston JH, McFarland R, Turnbull DM, Chinnery PF, Taylor RW (2009). Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children. Journal of Medical Genetics, 46(3), 209 - 214. doi:10.1136/jmg.2008.058180
    • Merrison AF, Hanna MG (2009). The bare essentials: muscle disease. Practical Neurology, 9(1), 54 - 65. doi:10.1136/jnnp.2008.167171
    • Tomlinson SE, Hanna MG, Holton JL, Rahman S (2009). A novel POLG1 mutation resulting in severe cachexia and muscle wasting.
    • Benevieste O, Hilton-Jones D, Hanna MG, Group IBMS (2009). First international 'Institute of Myology' workshop on Inclusion Body Myositis.. , , - .
    • Tomlinson SE, Burke D, Hanna MG, Bostock H, Koltzenburg M (2009). HOW REPRODUCIBLE ARE MULTIPLE NERVE EXCITABILITY PARAMETERS OVER TIME?.
    • Tomlinson SE, Burke D, Hanna MG, Koltzenburg M, Bostock H (2009). IN VIVO ASSESSMENT OF HCN CHANNEL FUNCTION (IH) IN HUMAN MOTOR AXONS.
    • Merrison AFA, Hanna MG (2009). Muscle disease. Practical Neurology, 9(1), 54 - 65. doi:10.1136/jnnp.2008.167171
    • Lunn M, Hanna M, Howard R, Parton M, Reilly M (2009). Nerve and muscle disease. In Clarke C, Howard R, Rossor M, Shorvon S (Ed.), Neurology: a Queen Square textbook (pp. 337 - 410). : Wiley-Blackwell.
    • Tomlinson SE, Burke D, Howells J, Trevillion L, Hanna MG, Koltzenburg M, Bostock H (2009). NOTCH APPEARANCE IN NERVE EXCITABILITY STUDIES: IDENTIFICATION AND IMPORTANCE.

    2008

    • Graves TD, Zuberi SM, Morris H, Schorge S, Kullmann DM, Hanna MG (2008). Episodic ataxia type 1 in identical twins: genotype-phenotype correlation.
    • Nirmalananthan N, Dick JRT, La Spada AR, Greensmith L, Hanna MG (2008). A co-inducer of the heat shock response ameliorates disease in a mouse model of SBMA. doi:10.1016/j.nmd.2008.06.140
    • Healy DG, Goadsby PJ, Kitchen ND, Yousry T, Hanna MG (2008). Spontaneous intracranial hypotension, hygromata and haematomata. Journal of Neurology, Neurosurgery and Psychiatry, 79(4), 442 - 442. doi:10.1136/jnnp.2007.132019
    • Healy DG, Goadsby PJ, Kitchen ND, Yousry T, Hanna MG (2008). Spontaneous intracranial hypotension, hygromata and haematomata. Journal of Neurology, Neurosurgery and Psychiatry, 79(4), 442 - 442. doi:10.1136/jnnp.2007.132019
    • Graves TD, Hanna MG (2008). Episodic ataxia: SLC1A3 and CACNB4 do not explain the apparent genetic heterogeneity. Journal of Neurology, 255(7), 1097 - 1099. doi:10.1007/s00415-008-0844-4
    • Taylor R, Fratter C, Sweeney MG, Poulton J, Brown GK, Rahman S, McFarland R, Seller A, Davis MB, Hanna MG, Turnbull DM (2008). The NCG Service for Rare Mitochondrial Disorders of Adults and Children: a clinical and molecular genetics perspective.
    • Duncan AJ, Sweeney MG, Stern E, Taylor RW, Woodward C, Davis MB, Hanna MG, Rahman S (2008). Identification of novel and recurrent mitochondrial DNA mutations in paediatric onset mitochondrial disease using the mitochip resequencing array.
    • Woodward C, Sweeney MG, Duncan AJ, Stern E, Al-Dosary M, Taylor RW, Hanna MG, Davis MB, Rahman S (2008). Comparative human mitochondrial genome analysis using the Affymetrix MitoChip and conventional cycle sequencing.
    • Matthews E, Tan SV, Fialho D, Sweeney MG, Sud R, Haworth A, Stanley E, Cea G, Davis MB, Hanna MG (2008). What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed. Neurology, 70(1), 50 - 53. doi:10.1212/01.wnl.0000287069.21162.94
    • Matthews E, Tan SV, Fialho D, Sweeney MG, Sud R, Haworth A, Stanley E, Cea G, Davis MB, Hanna MG (2008). What causes paramyotonia in the united kingdom?. NEUROLOGY, 70(1), 50 - 53.
    • Everett CM, Graves TD, Lad S, Jager HR, Thom M, Isenberg DA, Hanna MG (2008). Aggressive CNS lupus vasculitis in the absence of systemic disease activity. Rheumatology, 47(1), 107 - 109. doi:10.1093/rheumatology/kem264
    • Graves TD, Morris H, Zuberi S, Hanna MG, Kullmann DM, Schorge S (2008). Episodic ataxia type 1 in twins: Genotype-phenotype correlation.
    • Matthews E, Parton M, Humbel RL, Elliot P, Parry C, Holton J, Hanna MG (2008). Severe necrotising myopathy and cardiomyopathy with anti-signal recognition peptide antibodies. doi:10.1016/j.nmd.2008.06.165
    • Hall AM, Unwin RJ, Hanna MG, Duchen MR (2008). Renal function and mitochondrial cytopathy (MC): more questions than answers?. QJM, 101(10), 755 - 766. doi:10.1093/qjmed/hcn060
    • Graves TD, Imbrici P, Kors EE, Terwindt GM, Eunson LH, Frants RR, Haan J, Ferrari MD, Goadsby PJ, Hanna MG, van den Maagdenberg AMJM, Kullmann DM (2008). Premature stop codons in a facilitating EF-hand splice variant of Ca(V)2.1 cause episodic ataxia type 2. Neurobiology of Disease, 32(1), 10 - 15. doi:10.1016/j.nbd.2008.06.002
    • Fialho D, Kullmann DM, Hanna MG, Schorge S (2008). Non-genomic effects of sex hormones on CIC-1 may contribute to gender differences in myotonia congenita. doi:10.1016/j.nmd.2008.06.076
    • Rajakulendran S, Farmer S, Yousry T, Ashton E, Abbs S, Holton J, Hanna MG, Matthews E (2008). Marked hemi-atrophy in a manifesting carrier of Duchenne muscular dystrophy - Possible role of skewed X-inactivation. doi:10.1016/j.nmd.2008.06.275
    • Fialho D, Kullmann DM, Hanna MG, Schorge S (2008). Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita. Neuromuscular Disorders, 18(11), 869 - 872. doi:10.1016/j.nmd.2008.07.004
    • Matthews E, Guet A, Mayer M, Vicart S, Pemble S, Sternberg D, Fontaine B, Hanna MG (2008). Neonatal hypotonia can be a sodium channelopathy: recognition of a new phenotype. Neurology, 71(21), 1740 - 1742. doi:10.1212/01.wnl.0000335269.21550.0e
    • Matthews E, Guet A, Mayer M, Vicart S, Pemble S, Sternberg D, Fontaine B, Hanna MG (2008). Neonatal hypotonia can be a sodium channelopathy: recognition of a new phenotype.. Neurology, 71(21), 1740 - 1742. doi:10.1212/01.wnl.0000335269.21550.0e
    • Matthews E, Guet A, Mayer M, Vicart S, Pemble S, Sternberg D, Fontaine B, Hanna MG (2008). Neonatal hypotonia can be a sodium channelopathy. doi:10.1016/j.nmd.2008.06.080
    • Duncan AJ, Sweeney MG, Stern E, Taylor R, Woodward C, Davis MB, Hanna MG, Rahman S (2008). Comparative human mitochondrial genome analysis using the affymetrix Mitochip v2 and conventional cycle sequencing. doi:10.1016/j.nmd.2008.06.110
    • Graves TD, Zuberi SM, Morris H, Schorge S, Kullmann DM, Hanna MG (2008). Episodic ataxia type 1 in identical twins. doi:10.1016/j.nmd.2008.06.079

    2007

    • Nirmalananthan N, Dick JRT, Thomas PS, La Spada AR, Greensmith L, Hanna MG (2007). Physiological analysis of the phenotype of a YAC transgenic mouse model of Kennedy's disease.
    • Nirmalananthan N, Liolitsa D, Woodward C, Groves M, Reilly MM, Coker R, Hanna MG (2007). A novel phenotype associated with deficiency of mitochondrial complex IV activity.
    • Sisodiya S, Cross JH, Blumcke I, Chadwick D, Craig J, Crino PB, Debenham P, Delanty N, Elmslie F, Gardiner M, Golden J, Goldstein D, Greenberg DA, Guerrini R, Hanna M, Harris J, Harrison P, Johnson MR, Kirov G, Kullmann DM, Makoff A, Marini C, Nabbout R, Nashef L, Noebels JL, Ottman R, Pirmohamed M, Pitkanen A, Scheffer I, Shorvon S, Sills G, Wood N, Zuberi S (2007). Genetics of epilepsy: epilepsy research foundation workshop report. Epileptic Disorders, 9(2), 194 - 236. doi:10.1684/epd.2007.0107
    • Pope SAS, Chalasani A, Lyrics GW, Hargreaves IP, Oppenheim MLS, Hanna MG, Land JM, Heales SJR (2007). Mitochondrial dysfunction in association with cardiolipin deficiency. J INHERIT METAB DIS, 30, 70 - 70.
    • Ryan AM, Matthews E, Hanna MG (2007). Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias. Current Opinion in Neurology, 20(5), 558 - 563.
    • Cavalleri GL, Weale ME, Shianna KV, Singh R, Lynch JM, Grinton B, Szoeke C, Murphy K, Kinirons P, O'Rourke D, Ge D, Depondt C, Claeys KG, Pandolfo M, Gumbs C, Walley N, McNamara J, Mulley JC, Linney KN, Sheffield LJ, Radtke RA, Tate SK, Chissoe SL, Gibson RA, Hosford D, Stanton A, Graves TD, Hanna MG, Eriksson K, Kantanen AM, Kalviainen R, O'Brien TJ, Sander JW, Duncan JS, Scheffer IE, Berkovic SF, Wood NW, Doherty CP, Delanty N, Sisodiya SM, Goldstein DB (2007). Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. The Lancet Neurology, 6(11), 970 - 980. doi:10.1016/S1474-4422(07)70247-8
    • McKenzie M, Liolitsa D, Akinshina N, Campanella M, Sisodiya S, Hargreaves I, Nirmalananthan N, Sweeney MG, Abou-Sleiman PM, Wood NW, Hanna MG, Duchen MR (2007). Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption. Journal of Biological Chemistry, 282(51), 36845 - 36852. doi:10.1074/jbc.M704158200
    • Fialho D, Schorge S, Pucovska U, Davies NP, Labrum R, Haworth A, Stanley E, Sud R, Wakeling W, Davis MB, Kullmann DM, Hanna MG (2007). Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions.. Brain, 130(12), 3265 - 3274. doi:10.1093/brain/awm248
    • Graves TD, Zuberi SM, Schorge S, Kullmann DM, Hanna MG (2007). A clinical, genetic and electrophysiological study of a new UK episodic ataxia type 1 (EA1) pedigree.
    • Tomlinson SE, Hanna MG (2007). Acute neurology. Clinical Medicine, 7(3), 272 - 277.
    • Chinnery PF, Hudson G, Stewart J, Craig K, Taylor RW, Turnbull DM, Ramesh V, McFarland R, Burn DJ, Hanna MG, Horvath R, Lochmueller H, Zeviani M (2007). When and how should neurologists test for mutations in POLG?.
    • Ryan AM, Matthews E, Hanna MG (2007). Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.. Curr Opin Neurol, 20(5), 558 - 563. doi:10.1097/WCO.0b013e3282efc16c
    • Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW, CINCH investigators (2007). Primary episodic ataxias: diagnosis, pathogenesis and treatment. doi:10.1093/brain/awm126
    • van de Warrenburg BPC, Cordivari C, Ryan AM, Phadke R, Holton JL, Bhatia KP, Hanna MG, Quinn NP (2007). The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy. Movement Disorders, 22(16), 2325 - 2331. doi:10.1002/mds.21634
    • Tomlinson SE, Hanna MG (2007). Acute neurology (vol 7, pg 272, 2007). CLINICAL MEDICINE, 7(4), 324 - 324.
    • Graves TD, Zuberi SM, Schorge S, Kullmann DM, Hanna MG (2007). A clinical, genetic and electrophysiological study of a new UK episodic ataxia type 1 pedigree.
    • Graves TD, Kullmann DM, Hanna MG (2007). Episodic ataxia type 2 (EA2) is associated with epilepsy.
    • Craig K, Elliott HR, Keers SM, Lambert C, Pyle A, Graves TD, Woodward C, Sweeney MG, Davis MB, Hanna MG, Chinnery PF (2007). Episodic ataxia and hemiplegia caused by the 8993T→C mitochondrial DNA mutation. Journal of Medical Genetics, 44(12), 797 - 799. doi:10.1136/jmg.2007.052902
    • Hanna M, Graves T, Kullmann D (2007). Discussion. Epileptic Disorders, 9(2), 215 - 216.
    • Rajakulendran S, Schorge S, Kullmann DM, Hanna MG (2007). Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics, 4(2), 258 - 266. doi:10.1016/j.nurt.2007.01.010
    • Fialho D, Hanna MG (2007). Periodic paralysis. In Mastaglia FL, Hilton-Jones D (Ed.), Myopathies (pp. 77 - 106). : Elsevier.
    • Tomlinson SE, Hanna MG (2007). Acute neurology. CLIN MED, 7(3), 272 - 277.
    • Graves TD, Schorge S, Morris H, Kullmann DM, Hanna MG (2007). A novel voltage-sensing mutation in Kv1.1 is associated with episodic ataxia type 1.

    2006

    • Horvath R, Hudson G, Ferrari G, Fütterer N, Ahola S, Lamantea E, Prokisch H, Lochmüller H, McFarland R, Ramesh V, Klopstock T, Freisinger P, Salvi F, Mayr JA, Santer R, Tesarova M, Zeman J, Udd B, Taylor RW, Turnbull D, Hanna M, Fialho D, Suomalainen A, Zeviani M, Chinnery PF (2006). Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.. Brain, 129(Pt 7), 1674 - 1684. doi:10.1093/brain/awl088
    • Abou-Sleiman PM, Hanna MG, Wood NW (2006). Genetic association studies of complex neurological diseases. Journal of Neurology, Neurosurgery and Psychiatry, 77(12), 1302 - 1304.
    • Nirmalananthan N, Hanna MG (2006). Predicting steroid response in muscle disease. Journal of Neurology, Neurosurgery and Psychiatry, 77(10), 1104 - 1105.
    • Graves TD, Schorge S, Davies RA, Wood NW, Kullmann DM, Hanna MG (2006). The role of the brain P/Q-type calcium channel in human epilepsy. EUR J NEUROL, 13, 313 - 313.
    • Hudson G, Deschauer M, Taylor RW, Hanna MG, Fialho D, Schaefer AM, He LP, Blakely E, Turnbull DM, Chinnery PF (2006). POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. NEUROLOGY, 66(9), 1439 - 1441.
    • Hanna MG (2006). Genetic neurological channelopathies. Nature Clinical Practice Neurology, 2(5), 252 - 263.
    • Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ, Tristani-Firouzi M, Tawil R, Griggs RC (2006). The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain, 129(1), 8 - 17.

    2005

    • Pulkes T, Liolitsa D, Wills AJ, Hargreaves I, Heales S, Hanna MG (2005). Nonsense mutations in mitochondrial DNA associated with myalgia and exercise intolerance. Neurology, 64(6), 1091 - 1092.
    • Davies NP, Imbrici P, Fialho D, Herd C, Bilsland LG, Giunti P, Kullmann DM, Hanna MG, Weber A, Mueller R, Hilton-Jones D, Ealing J, Boothman BR, Parsons LM, Thomas M, Manzur AY, Chinnery PF, Rose M, Jurkat-Rott K, Lehmann-Horn F (2005). Andersen-Tawil syndrome: New potassium channel mutations and possible phenotypic variation. Neurology, 65(7), 1083 - 1089. doi:10.1212/01.wnl.0000178888.03767.74
    • Sultan SM, Allen E, Kiely P, Cooper RG, Oddis CV, Vencovsky J, Lundberg I, Dalmachi M, Hanna M, Isenberg DA (2005). Inter-rater reliability and validity of two disease activity assessment tools in patients with idiopathic inflammatory myositis (IIM).
    • Murphy RT, Mogensen J, McGarry K, Bahl A, Evans A, Osman E, Syrris P, Gorman G, Farrell M, Holton JL, Hanna MG, Hughes S, Elliott PM, Macrae CA, McKenna WJ (2005). Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. Journal of the American College of Cardiology, 45(6), 922 - 930.
    • Pulkes T, Liolitsa D, Eunson LH, Rose M, Nelson IP, Rahman S, Poulton J, Marchington DR, Landon DN, Debono AG, Morgan-Hughes JA, Hanna MG (2005). New phenotypic diversity associated with the mitochondrial tRNA (Ser(UCN)) gene mutation. Neuromuscular Disorders, 15(5), 364 - 371.
    • Gioltzoglou T, Cordivari C, Lee PJ, Hanna MG, Lees AJ (2005). Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature. Journal of Neurology, Neurosurgery and Psychiatry, 76(11), 1594 - 1596.
    • Everett CM, Graves TD, Lad S, Jager HR, Thom M, Isenberg DA, Hanna MG (2005). CNS Lupus in the absence of systemic disease activity.
    • Hanna MG, Cudia P (2005). Peripheral nerve diseases associated with mitochondrial respiratory chain dysfunction. In Dyck PJ, Thomas PK (Ed.), Peripheral neuropathy (pp. 1937 - 1949). : Elsevier Saunders.
    • Rossor MN, Hanna MG (2005). New year.... Journal of Neurology, Neurosurgery and Psychiatry, 76(1), 1 - 1. doi:10.1136/jnnp.2004.048926
    • Graves TD, Hanna MG (2005). Neurological channelopathies. Postgraduate Medical Journal, 81(951), 20 - 32.
    • Graves T, Imbrici P, Eunson L, Bhatia KP, Wodia NH, Hanna MG, Kullmann DM (2005). Late onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A.
    • Hanna MG, Graves TD, Jaffe SL, Imbrici P, Kullmann DM (2005). Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia-authors' response. Brain, 128(6), E33 - .
    • Eunson LH, Graves TD, Hanna MG (2005). New calcium channel mutations predict aberrant RNA splicing in episodic ataxia. Neurology, 65(2), 308 - 310.
    • Liolitsa D, McKenzie M, Hargreaves I, Heales S, Land J, Sisodiya SM, Wood NW, Duchen MR, Hanna MG (2005). MELAS, a young-onset stroke disorder associated with a homoplasmic ND5 mitochondrial DNA mutation. EUR J NEUROL, 12, 158 - 159.
    • Imbrici P, Eunson LH, Graves TD, Bhatia KP, Wadia NH, Kullmann DM, Hanna MG (2005). Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology, 65(6), 944 - 946.
    • Eunson LH, Graves TD, Hanna MG (2005). New calcium channel mutations predict aberrant RNA splicing in episodic ataxia. Neurology, 65(2), 308 - 310. doi:10.1212/01.wnl.0000169020.82223.dd
    • Sultan SM, Allen E, Cooper RG, Agarwal S, Oddis CV, Vencovsky J, Lundberg I, Kiely P, Hanna MG, Isenberg DA (2005). Inter-rater reliability of a new damage assessement tool in patients with idiopathic inflammatory myositis (IIM).

    2004

    • Rossor MN, Hanna MG (2004). New year, new editorial team. Journal of Neurology, Neurosurgery and Psychiatry, 75(1), 1 - .
    • Liolitsa D, Rahman S, Bentos S, Carr LJ, Hanna MG (2004). Is the Mitochondrial Complex 1 ND5 Gene a hot spot for MELAS causing mutations?. Annals of Neurology, (53), 128 - 132.
    • Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F International Myositis and Clinical Studies GIMACS (2004). International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.. Rheumatology, 43(1), 49 - 54.
    • McKenzie M, Liolitsa D, Hanna MG (2004). Mitochondrial disease: Mutations and mechanisms. Neurochemical Research, 29(3), 589 - 600.
    • Davies N, Beeson D, Brownlow S, Hanna M (2004). Congenital myasthenic syndrome with episodic apnoea: new mutations and an unusual complication.
    • McKenzie M, Liolitsa D, Sisodiya S, Wood N, Duchen M, Hanna M (2004). A homoplasmic ND5 mutation associated with MELAS: mitochondria as ATP consumers?.
    • Kinali M, Jungbluth H, Eunson LH, Sewry CA, Manzur AY, Mercuri E, Hanna MG, Muntoni F (2004). Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia. Neuromuscular Disorders, 14(10), 689 - 693. doi:10.1016/j.nmd.2004.06.007
    • Roedling S, Pearl D, Manji H, Hanna MG, Holton JL, Miller RF (2004). Unusual muscle disease in HIV infected patients. Sexually Transmitted Infections, 80(4), 315 - 317.
    • Hanna MG (2004). Episodic ataxia and migraine. EUR J NEUROL, 11, 341 - 341.
    • Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, Robertson R, Kullmann DM, Hanna MG (2004). Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain, 127(12), 2682 - 2692. doi:10.1093/brain/awh301
    • Nirmalananthan N, Holton JL, Hanna MG (2004). Is it really myositis? A consideration of the differential diagnosis. Current Opinion in Rheumatology, 16(6), 684 - 691.

    2003

    • Miller RF, Shahmonesh M, Hanna MG, Unwin RJ, Schapira AH, Weller IV (2003). Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors.. Antiviral Therapy, 8(3), 253 - 257.
    • Davies NA, Cochrane G, Hanna M (2003). Muscle disorders. In Greenwood RJ, Barnes MP, McMillan TM, Ward CD (Ed.), Handbook of neurological rehabilitation (pp. 705 - 725). : Psychology Press.
    • Liolitsa D, Rahman S, Benton S, Carr LJ, Hanna MG (2003). Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?. Annals of Neurology, 53(1), 128 - 132. doi:10.1002/ana.10435
    • Hanna M (2003). Disorders of muscle: introduction. In Warrell DA, Cox TM, Firth JD, Benz EJ (Ed.), Oxford Textbook of Medicine (pp. 1216 - 1220). : Oxford University Press.
    • Mundy HR, Jones SJ, Hobart JC, Hanna MG, Lee PJ (2003). A randomized controlled study of modified cobratoxin in adrenomyeloneuropathy. Neurology, 61(4), 528 - 530.
    • Brancati F, Valente EM, Davies NP, Sarkozy A, Sweeney MG, LoMonaco M, Pizzuti A, Hanna MG, Dallapiccola B (2003). Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. Journal of Neurology, Neurosurgery and Psychiatry, 74(9), 1339 - 1341.
    • Sultan R, Hanna MG, Rahman S, Isenberg DA (2003). International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.. Journal of Rheumatology, 43(1), 49 - 54.
    • Pulkes T, Liolitsa D, Nelson IP, Hanna MG (2003). Classical mitochondrial phenotypes without mtDNA mutations - The possible role of nuclear genes. Neurology, 61(8), 1144 - 1147.
    • Davies NP, Hanna MG (2003). The skeletal muscle channelopathies: distinct entities and overlapping syndromes. Current Opinion in Neurology, 16(5), 559 - 568.
    • Hargreaves IP, Heales SJR, Briddon A, Lee PJ, Hanna MG, Land JM (2003). Primary pyruvate dehydrogenase E3 binding protein deficiency with mild hyperlactataemia and hyperalaninaemia. Journal of Inherited Metabolic Disease, 26(5), 505 - 506.
    • Sorajja P, Sweeney MG, Chalmers R, Sachdev B, Syrris P, Hanna M, Wood ND, McKenna WJ, Elliott PM (2003). Cardiac abnormalities in patients with Leber's hereditary optic neuropathy. Heart, 89(7), 791 - 792.

    2002

    • Davies NP, Eunson LH, Hanna MG (2002). Results of a United Kingdom-wide clinical and molecular genetic study of myotonia congenita. J NEUROL NEUROSUR PS, 72(1), 137 - 137.
    • Jacques TS, Holton J, Watts PM, Wills AJ, Smith SE, Hanna MG (2002). Tubular aggregate myopathy with abnormal pupils and skeletal deformities. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73(3), 324 - 326.
    • Rea R, Spauschus A, Eunson LH, Hanna MG, Kullmann DM (2002). Variable K+ channel subunit dysfunction in inherited mutations of KCNA1. The Journal of Physiology, 538(1), 5 - 23.
    • Reilly MM, Hanna MG (2002). Genetic neuromuscular disease. Journal of Neurology, Neurosurgery and Psychiatry, 73(Suppl.2), II12 - II21.
    • Hanna MG, Wood NW (2002). Running a neurogenetic clinic. J NEUROL NEUROSUR PS, 73, 2 - 4.
    • Garrard P, Blake J, Stinton V, Hanna MG, Reilly MM, Holton JL, Landon DN, Honan WP (2002). Distal myopathy with tubular aggregates: a new phenotype associated with multiple deletions in mitochondrial DNA?. J NEUROL NEUROSUR PS, 73(2), 207 - 208.
    • Chinnery PF, Walls TJ, Hanna MG, Bates D, Fawcett PRW (2002). Normokalemic periodic paralysis revisited: Does it exist?. Annals of Neurology, 52(2), 251 - 252.
    • Davies NP, Weber A, Mueller R, Hilton-Jones D, Chinnery PF, Hanna MG (2002). Periodic paralysis, malignant ventricular arrhythmia and dysmorphism (Andersen's syndrome): A skeletal muscle potassium channel disorder. J NEUROL NEUROSUR PS, 73(2), 221 - 221.
    • Littleton ET, Man WD, Holton JL, Landon DN, Hanna MG, Polkey MI, Taylor GP (2002). Human T cell leukaemia virus type I associated neuromuscular disease causing respiratory failure. Journal of Neurology, Neurosurgery and Psychiatry, 72(5), 650 - 652.
    • McCabe DJH, Wood NW, Ryan F, Hanna MG, Connolly S, Moore DP, Redmond J, Barton DE, Murphy RP (2002). Intrafamilial phenotypic variability in Friedreich ataxia associated with a G130V mutation in the FRDA gene. Archives of Neurology, 59(2), 296 - 300.
    • Reilly MM, Hanna MG (2002). Genetic neuromuscular disease. J NEUROL NEUROSUR PS, 73, 12 - 21.
    • van den Maagdenberg AMJM, Terwindt GM, Kors EE, Imbrici P, Giffin NJ, Sherrington CR, van de Ven RCG, Hanna MG, Kullmann DM, Goadsby PJ, Ferrari MD, Frants RR (2002). Two novel mutations in the CACNA1A gene leading to identical functional consequences but with different phenotypic expression..
    • Davies NP, Beesley C, Elliott PM, Holton J, Lake B, Landon DN, Lee P, Mundy H, Winchester B, Hanna MG (2002). Intronic and missense mutations within the LAMP-2 gene in Danon disease (X linked vacuolar cardiomyopathy and myopathy). J NEUROL NEUROSUR PS, 72(1), 139 - 139.
    • Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Cooper R, Hanna M, Lundberg I, Oddis C, Plotz P, Vencovsky J, Rider L, Miller F (2002). Development of disease activity and damage indices for myositis: Further testing of four tools in adult onset patients..
    • Garrard P, Blake J, Stinton V, Hanna M, Reilly M, Holton J, Landon D, Honan W (2002). Distal myopathy with tubular aggregates: a new phenotype associated with multiple deletions in mitochondrial DNA?. Journal of Neurology, Neurosurgery and Psychiatry, 73(2), pp.207 - 208.
    • Davies NP, Sutton I, Winer JB, Moorcroft P, Hall HS, Cole T, Davies MB, Valente EM, Brancati F, Hammons SR, Hanna MG (2002). The sodium channel syndromes: Expanding the phenotype associated with SCN4A mutations. J NEUROL NEUROSUR PS, 73(2), 229 - 229.
    • Ward KN, White RP, MacKinnon S, Hanna M (2002). Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient. Bone Marrow Transplantation, 30(12), 983 - 985.
    • Anderson LVB, Bushby KMD, Hanna MG, Muntoni FN, Hilton-Jones D, Newsom-Davis J (2002). Diagnosing rare neuromuscular diseases - The jump from research to service.
    • Chong MS, Smith TE, Hanna M (2002). Case reports - reversal of sensory deficit associated with pain relief after treatment with gabapentin. PAIN, 96(3), 329 - 333. doi:10.1016/S0304-3959(01)00468-7
    • Davies NP, Weber A, Mueller R, Hilton-Jones D, Chinnery PF, Hanna MG (2002). Andersen's syndrome: A skeletal muscle potassium channel disorder.
    • Liolitsa D, Hanna MG (2002). Models of mitochondrial disease. International Review of Neurobiology, 53, 429 - 466.
    • Kullmann DM, Hanna MG (2002). Neurological disorders caused by inherited ion-channel mutations. The Lancet Neurology, 1(3), 157 - 166.

    2001

    • Wood NW, Kinton L, Hanna MG (2001). Genetics of the overlap between epilepsy and movement disorders. In Guerrini R, Aicardi J, Andermann F, Hallett M (Ed.), Epilepsy and movement disorders (pp. 451 - 464). : Cambridge University Press.
    • Davies NP, Hanna MG (2001). The skeletal muscle channelopathies: basic science, clinical genetics and treatment. Current Opinion in Neurology, 14(5), 539 - 551.
    • Davies NP, Hanna MG (2001). The genetic neurological channelopathies. In Scolding N (Ed.), Contemporary treatments in neurology (pp. 398 - 440). : Butterworth-Heinemann.
    • Zuberi SM, Hanna MG (2001). Ion channels and neurology. Archives of Disease in Childhood, 84(3), 277 - 280.
    • Pulkes T, Hanna MG (2001). Human mitochondrial DNA diseases. Advanced Drug Delivery Reviews, 49(1-2), 27 - 43.
    • Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, Kullmann DM, Hanna MG (2001). Human epilepsy associated with dysfunction of the brain P/Q- type calcium channel. The Lancet, 358(9284), 801 - 807. doi:10.1016/S0140-6736(01)05971-2
    • Davies NP, Eunson LH, Samuel M, Hanna MG (2001). Sodium channel gene mutations in hypokalemic periodic paralysis: An uncommon cause in the UK. Neurology, 57(7), 1323 - 1325.
    • Davies NP, Hanna MG (2001). Inherited muscle and brain channelopathies.. Expert Rev Neurother, 1(2), 247 - 265. doi:10.1586/14737175.1.2.247
    • Davies NP, Hanna MG (2001). The skeletal muscle channelopathies: basic science, clinical genetics and treatment (vol 14, pg 541, 2001). CURRENT OPINION IN NEUROLOGY, 14(6), 845 - 845.

    2000

    • Eunson LH, Rea R, Zuberi SM, Youroukos S, Panayiotopoulos CP, Liguori R, Avoni P, McWilliam RC, Stephenson JBP, Hanna MG, Kullmann DM, Spauschus A (2000). Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Annals of Neurology, 48(4), 647 - 656.
    • Jouvenceau A, Eunson L, Spauschus A, Ramesh V, Hanna MG, Kullmann DM (2000). Non-functional alpha(1A) calcium channel in episodic ataxia type 2. J PHYSIOL-LONDON, 525, 75P - 75P.
    • Jouvenceau A, Eunson L, Spauschus A, Ramesh V, Hanna MG, Kullmann DM (2000). Premature termination in the CACNA1A gene observed in episodic ataxia type 2 (EA2) results in a loss of alpha1A calcium channel function.. EUR J NEUROSCI, 12, 454 - 454.
    • Cottrell DA, Blakely EL, Johnson MA, Chinnery PF, Hanna M, Turnbull DM (2000). Neuropathological and histochemical changes in a multiple mitochondrial DNA deletion disorder. J NEUROPATH EXP NEUR, 59(7), 621 - 627.
    • Rea R, Spauschus A, Eunson L, Hanna MG, Kullmann DM (2000). Functional analysis of interactions between wild-type and mutant subunits of hKv1.1 in episodic ataxia type 1. J PHYSIOL-LONDON, 525, 76P - 76P.
    • Pulkes T, Wills AJ, Hanna MG (2000). Exercise intolerance associated with a novel stop codon mutation in the mitochondrial ND2 gene. ANNALS OF NEUROLOGY, 48(3), 469 - 469.
    • Spauschus A, Rea R, Eunson L, Wood NW, Hanna MG, Kullmann DM (2000). Functional characterisation of mutant Kv1.1 subunits from two families with episodic ataxia type 1. J PHYSIOL-LONDON, 523, 156P - 157P.
    • Pulkes T, Sweeney MG, Hanna MG (2000). Increased risk of stroke in patients with the A12308G polymorphism in mitochondria. The Lancet, 356(9247), 2068 - 2069.
    • Pulkes T, Eunson L, Siddiqui A, Morgan-Hughes JA, Hanna MG, Wood NW, Nelson IP, Patterson V (2000). Erratum: (Annals of Neurology (1999) 46 (916-919)). Annals of Neurology, 47(6), 841 - 841.
    • Davies NP, Eunson LH, Gregory RP, Mills KR, Morrison PJ, Hanna MG (2000). Clinical, electrophysiological, and molecular genetic studies in a new family with paramyotonia congenita. Journal of Neurology, Neurosurgery and Psychiatry, 68(4), 504 - 507.
    • Pulkes T, Siddiqui A, Morgan-Hughes JA, Hanna MG (2000). A novel mutation in the mitonchondrial tRNA(Tyr) gene associated with exercise tolerance. Neurology, 55(8), 1210 - 1212.
    • Munchau A, Valente EM, Shahidi GA, Eunson LH, Hanna MG, Quinn NP, Schapira AHV, Wood NW, Bhatia KP (2000). A new family with paroxysmal exercise induced dystonia and migraine: a clinical and genetic study. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 68(5), 609 - 614.
    • Rahman S, Lake BD, Taanman JW, Hanna MG, Cooper JM, Shapira AHV, Leonard JV (2000). Cytochrome C oxidase immunohistochemistry: Clues for genetic mechanisms. Brain, 123(3), 591 - 600.
    • Spauschus A, Rea R, Eunson L, Hanna MG, Kullmann DM (2000). Mutations of Kv1.1 found in patients with episodic ataxia type 1 (EA1) affect the open probability of channels in vitro. EUR J NEUROSCI, 12, 25 - 25.

    1999

    • Hanna MG, Nelson IP (1999). Genetics and molecular pathogenesis of mitochondrial respiratory chain diseases. Cellular and Molecular Life Sciences, 55(5), 691 - 706.
    • Vergani L, Rossi R, Holt IJ, Brierley CH, Hanna M (1999). Introduction of heteroplasmic mitochondrial DNA (mtDNA) from a patient with NARP into two human ρ(°) cell lines is associated either with selection and maintenance of NARP mutant mtDNA or failure to maintain mtDNA. Human Molecular Genetics, 8(9), 1751 - 1755. doi:10.1093/hmg/8.9.1751
    • Eunson LH, Davis MB, Wood NW, Hanna MG (1999). The national DNA-based diagnostic service for periodic paralyses. Journal of Medical Genetics, 36, S63 - .
    • Pulkes T, Eunson L, Patterson V, Siddiqui A, Wood NW, Nelson IP, Morgan-Hughes JA, Hanna MG (1999). The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS. Annals of Neurology, 46, 916 - 919.
    • Marques W, Hanna MG, Marques SR, Sweeney MG, Thomas PK, Wood NW (1999). Phenotypic variation of a new P0 mutation in genetically identical twins. Journal of Neurology, 246(7), 596 - 599.
    • Hanna MG (1999). Case 22. In Wills AJ, Marsden CD (Ed.), Fifty neurological cases from the National Hospital (pp. 71 - 74). : Martin Dunitz.
    • Clark KM, Taylor RW, Johnson MA, Chinnery PF, Chrzanowska-Lightowlers ZMA, Andrews RM, Nelson IP, Wood NW, Lamont PJ, Hanna MG, Lightowlers RN, Turnbull DM (1999). An mtDNA mutation in the initiation codon of the cytochrome C oxidase subunit II gene results in lower levels of the protein and a mitochondrial encephalomyopathy. The American Journal of Human Genetics, 64(5), 1330 - 1339.
    • Elliott PM, Hanna MG, Ward SA, Chinnery PF, Turnbull DM, Wood NW, McKenna WJ (1999). Diagnostic utility of metabolic exercise testing in a patient with cardiovascular disease. Heart, 81(4), 441 - 443.
    • Spauschus A, Eunson L, Hanna MG, Kullmann DM (1999). Functional characterization of a novel mutation in KCNA1 in episodic ataxia type 1 associated with epilepsy.. Ann N Y Acad Sci, 868, 442 - 446.
    • Zuberi SM, Eunson LH, Spauschus A, De Silva R, Tolmie J, Wood NW, McWilliam RC, Stephenson JB, Kullmann DM, Hanna MG (1999). A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy.. Brain, 122 ( Pt 5), 817 - 825.
    • Sweeney MG, Giunti P, Stinton VJ, Worth PF, Hanna MG, Wood NW, Davis MB (1999). Population genetics of the SCA6 locus in British families with ADCA.. AM J HUM GENET, 65(4), A400 - A400.
    • Eunson LH, Jouvenceau A, Ramesh V, Zuberi SM, Nairne A, Hyman N, Wood NW, Spauschus A, Kullmann DM, Hanna MG (1999). New mutations in the voltage-gated calcium channel gene CACNA1A in british families with episodic ataxia type 2.. AM J HUM GENET, 65(4), A293 - A293.
    • Eunson L, Davies NP, Davis MB, Gregory RP, Mills KR, Morrison PJ, Hanna MG (1999). Genetic diagnosis of paramyotonia congenita - exon 24 of the skeletal muscle sodium channel (SCN4A) gene is a hot spot for mutations. Journal of Medical Genetics, 36, S63 - .
    • Andreu AL, Hanna MG, Morgan-Hughes J, Reichmann H, Bruno C, Penn AS, Iwata S, Lach B, DiMauro S, Tanji K, Pallotti F, Bonilla E (1999). Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. New England Journal of Medicine, 341(14), 1037 - 1044. doi:10.1056/NEJM199909303411404
    • Andreu AL, Hanna MG, Reichmann H, Bruno C, Penn AS, Tanji K, Pallotti F, Iwata S, Bonilla E, Lach B, Morgan-Hughes J, Di Mauro S (1999). Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. New England Journal of Medicine, 341(14), 1037 - 1044.
    • Hanna MG (1999). Case 8. In Wills AJ, Marsden CD (Ed.), Fifty neurological cases from the National Hospital (pp. 23 - 25). : Martin Dunitz.
    • Rahman S, Taanman JW, Cooper JM, Nelson I, Hargreaves I, Meunier B, Hanna MG, Garcia JJ, Capaldi RA, Lake BD, Leonard JV, Schapira AHV (1999). A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy. The American Journal of Human Genetics, 65(4), 1030 - 1039.
    • Davies NP, Hanna MG (1999). Neurological channelopathies: diagnosis and therapy in the new millennium.. Ann Med, 31(6), 406 - 420.
    • Rudel R, Hanna MG, Lehmann-Horn F (1999). Muscle channelopathies: malignant hyperthermia, periodic paralyses, paramyotonia, and myotonia. In Schapira AHV, Griggs RC (Ed.), Muscle diseases (pp. 135 - 175). : Butterworth-Heinemann.
    • Morgan-Hughes JA, Hanna MG (1999). Mitochondrial encephalomyopathies: the enigma of genotype versus phenotype. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1410(2), 125 - 145.

    1998

    • Leff AP, Mcnabb AW, Hanna MG, Clarke CR, Larner AJ (1998). Complex partial status epilepticus in late-onset MELAS. Epilepsia, 39, 438 - 441.
    • Hanna MG, Davis MB, Sweeney MG, Noursadeghi M, Ellis C, Elliott P, Wood NW (1998). Generalised chorea in two patients harbouring Friedrich's ataxia trinucleotide repeat expansion. Movement Disorders, 13, 339 - 340.
    • Hanna MG, Wood NW, Kullmann DM (1998). Ion channels and neurological disease: DNA based diagnosis is now possible, and ion channels may be important in common paroxysmal disorders. Journal of Neurology, Neurosurgery and Psychiatry, 65, 427 - 431.
    • Hanna MG, Nelson IP, Morgan-Hughes JA, Wood NW (1998). MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. Journal of Neurology, Neurosurgery and Psychiatry, 65, 512 - 517.
    • Hanna MG, Stewart J, Schapira AHV, Wood NW, Morgan-Hughes JA, Murray NMF (1998). Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). Journal of Neurology, Neurosurgery and Psychiatry, 65, 248 - 250.
    • Hanna MG, Nelson IP, Rahman S, Lane RJM, Land J, Heales S, Cooper MJ, Schapira AHV, Morgan-Hughes JA, Wood NW (1998). Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA. The American Journal of Human Genetics, 63(1), 29 - 36.

    1997

    • Nelson I, Hanna MG, Wood NW, Harding AE (1997). Depletion of mitochondrial DNA by ddC in untransformed human cell lines.. Somat Cell Mol Genet, 23(4), 287 - 290.
    • Hanna MG, Davis MB, Sweeney MG, Nousanjani M, Ellis C, Elliott P, Wood NW (1997). Generalised chorea in two patients harbouring Friedrich's ataxia trinucleotide repeat expansion. Movement Disorders, , - .
    • Nelson I, Hanna MG, Wood NW, Harding AE (1997). Depletion of mtDNA by ddC in untransformed human cell lines. Somatic Cell and Molecular Genetics, , - .
    • Hanna MG, Vaughan JR, Silburn PA, Davis PTG, Greenhall RCD, Squier MV, Mills KR, Renowden S, Sellar A (1997). Two unusual clinical presentations of the mitochondrial DNA, A3243G point mutation in adult neurological practice. Journal of Neurology, Neurosurgery and Psychiatry, 62, 544 - 546.
    • Hanna MG, Mills KR, Pazdera L, Newsom-Davis J (1997). Primary orthostatic tremor with prominent muscle hypertrophy. Neurology, 49, 872 - 874.
    • Hanna MG, Bhatia KP (1997). Movement disorders and mitochondrial dysfunction. Current Opinion in Neurology, 10, 351 - 356.
    • Hanna MG, Nelson IP, Rahman S, Schapira AHV, MorganHughes JA, Wood NW (1997). Cytochrome c oxidase deficiency associated with a new stop codon mutation in mitochondrial DNA.

    1995

    • HANNA MG, NELSON IP, MORGANHUGHES JA, HARDING AE (1995). IMPAIRED MITOCHONDRIAL TRANSLATION IN HUMAN MYOBLASTS HARBORING THE MITOCHONDRIAL-DNA TRANSFER-RNA LYSINE-8344 A-]G (MERRF) MUTATION - RELATIONSHIP TO PROPORTION OF MUTANT MITOCHONDRIAL-DNA (VOL 130, PG 154, 1995). J NEUROL SCI, 132(1), 95 - 95.
    • Hanna MG, Nelson I, Sweeney MG, Cooper JM, Watkins PJ, Morgan-Hughes JA, Harding AE (1995). Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation.. Am J Hum Genet, 56(5), 1026 - 1033.
    • Hanna MG, Nelson I, Sweeney MG, Cooper JM, Watkins PJ, Morgan-Hughes JA, Harding AE (1995). Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation.. The American Journal of Human Genetics, 56(5), 1026 - 1033.
    • Nelson I, Hanna MG, Alsanjari N, Scaravilli F, Morgan-Hughes JA, Harding AE (1995). A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological, and molecular genetic study.. Ann Neurol, 37(3), 400 - 403. doi:10.1002/ana.410370317
    • Hanna MG, Nelson IP, Morgan-Hughes JA, Harding AE (1995). Impaired mitochondrial translation in human myoblasts harbouring the mitochondrial DNA tRNA lysine 8344 A-->G (MERRF) mutation: relationship to proportion of mutant mitochondrial DNA.. J Neurol Sci, 130(2), 154 - 160.
    • HANNA M (1995). VITAMIN-E-DEFICIENCY. BRITISH MEDICAL JOURNAL, 310(6995), 1673 - 1673.
    • Hammans SR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE (1995). The mitochondrial DNA transfer RNALeu(UUR) A-->G(3243) mutation. A clinical and genetic study.. Brain, 118 ( Pt 3), 721 - 734.
    • Hanna MG, Nelson IP, Morgan-Hughes JA, Harding AE (1995). Erratum: Impaired mitochondrial translation in human myoblasts harbouring the mitochondrial DNA tRNA lysine 8344 A → G (MERRF) mutation: Relationship to proportion of mutant mitochondrial DNA (J. Neurol. Sci. (1995) 130 (154-160)). Journal of the Neurological Sciences, 132(1), 95 - 95. doi:10.1016/0022-510X(95)00199-C

    1989

    • SELAM J, KASHYAP M, ALBERTI K, LOZANO J, HANNA M, TURNER D, JEANDIDIER N, CHAN E, CHARLES M (1989). COMPARISON OF INTRAPERITONEAL AND SUBCUTANEOUS INSULIN ADMINISTRATION ON LIPIDS, APOLIPOPROTEINS, FUEL METABOLITES, AND HORMONES IN TYPE-I DIABETES-MELLITUS. METABOLISM-CLINICAL AND EXPERIMENTAL, 38(9), 908 - 912. doi:10.1016/0026-0495(89)90240-0

    • Hanna M, Statland JM, Bundy BN, Wang Y, Rayan DR, Triveldi JR, Sansone VA, Salajegheh MK, Venance SL, Ciafaloni E, Matthews E, Meola G, Herbelin L, Griggs RC, Barohn RJ (). Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomised contrlled trial. JAMA: Journal of the American Medical Association, 308(13), 1357 - 1365. doi:10.1001/jama.2012.12607
    • Jaffer F, Reilly MM, Quinlivan R , Muntoni F, Orrell R, Wraige E, Radunovic A, Mummery C, Hanna MG (). Avoiding unplanned admissions in patients with neuromuscular diseases: a regional collaborative audit of hospital admissions 2009-2011.